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Thesis Abstract 
 
Receiving an Uncertain Diagnosis: 
Experiences and Discourses 
 
With watchful waiting being increasingly considered as a reasonable alternative for curative 
treatments for some men with localised prostate cancer, this review aimed to explore the 
psychological impact of this treatment decision. The review showed that initially aspects of 
psychological wellbeing were negatively affected, possibly due to uncertainty around 
treatment choice and the ongoing experience of living with cancer. However over time men 
appeared to adjust and reported similar wellbeing scores to men in other treatment groups. 
Men with localised prostate cancer therefore need to be appropriately supported to manage the 
uncertainty related to watchful waiting. 
 
In continuation of the exploration of uncertainty in illness, seven people with a diagnosis of 
Mild Cognitive Impairment (MCI) were interviewed. MCI has an uncertain prognosis, 
whereby the cognitive changes may progress to dementia, remain stable or return to normal 
over time. The interviews were analysed using discourse analysis, in order to identify how the 
language used revealed societal views, shared meanings and positions taken by people. Three 
main discourses emerged. A discourse of ‘Not Knowing’ appeared for MCI. In the absence of 
a coherent discourse around MCI, participants positioned themselves between ‘Knowing’ 
about ageing and dying, and ‘Not Wanting to Know’ about dementia. How a diagnosis of 
MCI is shared and how further information is presented needs to be considered by clinicians, 
so that the person with a diagnosis of MCI can find a more supportive position, rather than 
finding themselves oscillating between discourses related to ageing and dying, and dementia. 
 
Contributions to theory development, future research and clinical practice were considered in 
respect to prostate cancer and MCI. The overlapping theme of uncertainty was discussed in 
relation to both conditions and how this can inform shared learning and clinical practice. 
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Abstract 
 
Active and aggressive treatments, with physical side effects, are no longer the only option for 
treating prostate cancer. Watchful waiting is becoming viewed as a reasonable alternative, 
whereby men are able to conservatively monitor disease progression with the knowledge that 
if the disease progresses, palliative treatment options remain available. This review aimed to 
identify the psychological consequences of watchful waiting on men with prostate cancer. An 
electronic search of the literature was conducted, and 14 studies identified that met inclusion 
criteria (12 quantitative and two qualitative studies). Watchful waiting was found to have 
little impact on sexual problems. Improvements in anxiety and depression scores were found 
when watchful waiting was compared to men in hormone therapy. However, significantly 
poorer scores were found in the watchful waiting group in the areas of quality of life, anxiety 
and depression, both over time and compared to other treatment groups, although this was not 
shown in all studies. In the two qualitative studies, uncertainty was found to play a role in 
both the decision making process and the ongoing experience of living with cancer. Initially, 
uncertainty around watchful waiting may negatively impact on psychological wellbeing, 
however over time men adjust to this treatment choice with outcomes generally similar to 
men in other treatment groups. Heterogeneity of studies, in regards to design, measures and 
data collected, was a limitation of this review.  Future research into this area should focus on 
more consistent data collection and reporting, allowing men to make a more informed choice, 
and physicians to psychologically support these men appropriately. 
 
Keywords: Anxiety, Depression, Mental Health, Prostate Cancer, Quality of Life, Sexual 
Functioning, Uncertainty, Watchful Waiting. 
 
Research Highlights 
 Watchful waiting initially impacts negatively on aspects of psychological wellbeing. 
 Uncertainty in watchful waiting may influence psychological wellbeing. 
 Over time men tend to adjust to the uncertainty and watchful waiting treatment. 
 Men should be supported to manage the uncertainty around treatment choice. 
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Introduction 
 
Western culture values taking action to treat physical illnesses, and public messages such as 
‘fighting cancer’ mean that when diagnosed, a military mentality is encouraged, leading to an 
active stance to treat and intervene as quickly as possible (Payer, 1996; Harrington, 2012). 
However, active and aggressive treatments are no longer the only route patients are offered, 
depending on the diagnosis and prognosis. An increasing number of conditions now have the 
treatment option of ‘watchful waiting’, where ongoing monitoring of the condition takes 
place, but no active intervention or treatment is undertaken until the condition meets certain 
criteria. Conditions where this approach might be indicated include prostate cancer, small 
abdominal aortic aneurysms (Katz, Littenberg & Cronenwett, 1992), and renal tumours 
(Kouba, Smith, McRackan, Wallen & Pruthi, 2007). The psychological impact of a watchful 
waiting regime for men diagnosed with localised prostate cancer is the focus of this review. 
 
Prostate Cancer 
 
Prostate cancer is the most common cancer in men in the United Kingdom, accounting for 
25% of all new cancers in men. Incidence rates rise sharply from 50-54 years, reaching an 
overall peak in the 75-79 age group (Prostate Cancer Incidence Statistics, 2011). Recently, 
early detection of prostate cancer, through the use of Prostate Specific Antigen (PSA) 
screening, has led to an increase in incident rates (Klotz, 2005). Hence, diagnoses are often 
made when tumours are non-palpable and localised to the prostate gland, and ten years or 
more may pass before the prostate cancer progresses to be clinically symptomatic (Wilt & 
Partin, 2003). As a result of these advances, men with indolent tumours can be over treated 
(Bailey & Wallace, 2007; Hegarty et al., 2010).  All treatment strategies for localised prostate 
cancer carry significant risks of adverse effects, such as sexual dysfunction, urinary 
incontinence and bowel problems (Wilt & Partin, 2003), which can significantly reduce 
quality of life (Harlan et al., 2003).  
 
In the past, studies and reviews into optimal treatment methods for prostate cancer have 
focussed on morbidity and survival rates. However, the preferential treatment remains 
undefined (Namiki & Arai, 2010), and some studies have suggested that survival rates are 
generally similar across treatment groups, including watchful waiting (Drachenberg, 2000; 
Wilt et al., 2012). Physical side effects of treatments can have an enduring impact on both 
physical and psychological wellbeing. As a result, prolonged life expectancy is not the only 
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consideration when a making a decision about treatment for prostate cancer. Quality of life 
has also become an important factor in the decision making process (Litwin, Lubeck, 
Spitalny, Henning & Carroll, 2002; Couper, 2007).  
 
Psychological Consequences of Watchful Waiting as a Treatment Option 
 
The issues above have led physicians and some patients to choose not to aggressively treat 
the prostate cancer, and instead intermittently observe its progress. The literature has 
focussed on two primary observation and monitoring protocols for men with prostate cancer: 
active surveillance and watchful waiting. Active surveillance delays curative treatment (such 
as radical prostatectomy) until it is warranted based on indicators of disease progression 
(Weissbach & Altwein, 2009). In comparison, watchful waiting is a conservative 
management strategy for men who are more likely to die from comorbidities. Palliative 
treatments (such as hormone therapy) are available, where there is symptomatic disease 
progression (Parker, 2003; Klotz, 2005). However, historically these terms have often been 
used inconsistently and interchangeably in the literature without specific definitions (Ganz et 
al., 2012), confusing the literature on observation (Ip et al., 2011). This review’s focus is 
watchful waiting, whereby the term means regular observations with the provision of 
palliative treatment if the disease progresses.  
 
The decision to adopt a watchful waiting approach by physicians and patients considers a 
number of factors, including age, other medical conditions and tumour qualities, and it is 
considered to be an option for elderly men with less aggressive tumours or patients with 
limited life-expectancy (Heidenreich et al., 2008). Previously, men chose watchful waiting 
with the expectation that they would die from causes other than prostate cancer. Now men 
choose watchful waiting in order to actively evaluate the cancer progression with the 
knowledge that palliative treatment remains an option (Wallace, Bailey, O'Rourke & 
Galbraith, 2004). 
 
Whilst watchful waiting allows men the option of monitoring their prostate cancer, with 
fewer physical side effects from the cancer and aggressive curative treatments, and 
potentially without a reduced life expectancy, these men live with the knowledge that they 
have cancer. In light of the current beliefs around cancer (Payer, 1996; Harrington, 2012) and 
the desire for treatment and cure, how do men who have been offered watchful waiting 
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manage their psychological wellbeing, and what are the psychological consequences of this 
treatment option?  
 
Method 
 
Search Strategy 
 
Electronic searches were carried out using PsycINFO, Pubmed, and Web of Knowledge 
databases, across all years (up to February 2015), to identify relevant material.  
 
The keyword combinations used in the search were: 
 “prostate cancer” AND 
 “watchful waiting” “expectant management” “conservative management” AND 
 “quality of life” “psych*” “anxiety” “depression” “wellbeing”  
 
Studies were included based on inclusion and exclusion criteria: 
 Available in English. 
 Reported data from men with localised prostate cancer. 
 Quantitative studies must include psychological wellbeing measures from one or more 
of the following categories: quality of life, anxiety, depression, uncertainty, sexual 
functioning. 
 Qualitative studies must include reports of the psychological aspects of watchful 
waiting. 
 Data was reported from patients undertaking watchful waiting treatment for prostate 
cancer, whereby watchful waiting was defined as a conservative management strategy 
where the aim was purely palliative. 
 Studies reporting a definition of active surveillance (delayed curative treatment) were 
excluded. 
 
Across the three electronic databases, 675 studies were identified, using searches with 
combinations of the terms detailed above in the abstract, title or topic. Based on the above 
inclusion and exclusion criteria, 629 studies were excluded. The remaining 46 studies were 
assessed using full text for eligibility using the above criteria. Fourteen papers were included 
in the review (Figure 1).  
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Insert Figure 1. 
 
Quality Assessment 
 
There is no consensus on the criteria to be used for the critical appraisal of the 
methodological quality of studies in reviews which include qualitative, quantitative, and 
mixed methods studies. However, the Mixed Methods Appraisal Tool (MMAT; Pluye, 
Gagnon, Griffiths & Johnson-Lafleur, 2009; Pluye, 2011) is a recently developed tool that 
has demonstrated an intra-class correlation of 0.8 based on pilot testing (Pluye et al., 2009). 
Scores vary from 25% (* - one criterion met), to 100% (**** - all criteria met) (Appendix 
1.1). Quality assessment scores using the MMAT were calculated for the 14 studies included 
in this review and are reported in Table 1. Nine studies met 100% of criteria, four studies met 
75% of criteria, and one study met 50% of criteria.  
 
Data extraction and synthesis 
 
Data was extracted from the 12 quantitative studies on the study design, sample 
characteristics and psychological wellbeing measures. As a result of the variety of measures 
used, and data collected and reported in the studies, there was no clear way of grouping the 
studies by design. Instead, all data regarding psychological wellbeing was extracted and 
grouped into four outcomes relevant for this review: quality of life, anxiety, depression, and 
sexual problems.  
 
Qualitative data on psychological wellbeing was gained from two studies included in the 
review. A thematic analysis of the results of the two studies was undertaken. Data from the 
results sections were coded, and grouped into two themes: “an uncertain treatment decision”, 
and “coping with uncertainty”. 
 
Results 
 
Study characteristics 
 
Characteristics of the studies are reported in Table 1. The studies were completed between 
the years of 1999 and 2011. 
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Participants  
Overall, 6403 men diagnosed with prostate cancer with a mean age of 67.7 (calculated from 
11 studies reporting mean age) took part in the 14 studies across all treatment groups. The 
mean age of men undertaking watchful waiting was 70.2 (calculated from ten studies 
reporting mean age). Six of the 14 studies used age as an exclusion criterion; one study 
included participants aged under 70, four studies included participants aged under 75, and 
one study included participants aged under 89.  
 
Nine studies were conducted in the United States, one study in Australia, three in Sweden and 
Finland, and one in the Netherlands. 
 
Design 
Of the twelve quantitative studies, two were randomised control trials, nine were cohort 
studies, and one study was cross-sectional with a cohort sample subset. Eleven of the 
quantitative studies made comparisons between treatment groups, whilst one study only 
followed patients undergoing watchful waiting. Of the two qualitative studies, one used a 
fundamental qualitative description method and one study used a phenomenologic 
hermeneutic approach. 
 
Interventions 
A number of treatment options for prostate cancer were compared with watchful waiting, 
including radiation therapies, hormone therapies and surgery.  
 
Measures 
Eight studies used the Medical Outcomes Study Short Form-36 (Rand SF-36, also known as 
the MOS SF-36; Hays, Sherbourne & Mazel, 1993; Ware, Kosinski, Dewey & Gandek, 
2000), which is a valid and reliable measure with test-retest reliability and good internal 
consistency (Ware & Sherbourne, 1992). It measures eight health concepts which can be 
grouped into physical health and mental health component summaries. The data from the 
mental health component summary is included in this review, and is defined by questions 
related to mood and anxiety symptoms.  
 
The University of California at Los Angeles Prostate Cancer Quality of Life Index (UCLA; 
Litwin et al., 1998) was used by four studies and has six subscales. Two aspects of sexual 
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problems are assessed; sexual functioning and sexual bother. When validating the UCLA, 
Litwin et al. (1998) found that although participants often reported that sexual function was 
poor, they had adjusted to the change and were not particularly bothered. As this review is 
focussing on the psychological aspects of sexual problems, only the data for sexual bother is 
reported in this review. 
 
Two studies used a study specific questionnaire (Johansson et al., 2011; Steineck et al., 
2002), which included 141 questions exploring psychological symptoms, sense of wellbeing, 
and quality of life on a seven point visual digital scale, which was validated in an 
unpublished pilot study. Five measures were used to assess quality of life (Table 2), two 
measures were used to assess anxiety and depression (Table 4), and four measures were used 
to assess sexual problems (Table 6). 
 
Insert Table 1. 
 
Quantitative findings 
 
Quality of life 
Quality of life was assessed by six studies included in the review, using a range of 
questionnaires. The findings are reported in Table 2.  
 
Insert Table 2. 
 
Through post hoc analysis, Galbraith, Ramirez & Pedro (2001) found that at 12 months, men 
undergoing watchful waiting reported lower health related quality of life than those 
undergoing mixed beam (p=0.02) or proton beam radiation (p=0.05). By 18 months watchful 
waiting participant’s scores had improved and there was no longer a significant difference 
between watchful waiting participants and other treatment groups.  
 
Johansson et al. (2011) found high self-assessed quality of life reported at a median of 4.1 
years by 69% and at a median of 12.2 years by 24% in the watchful waiting group, and by 
70% and 36% in the radical prostatectomy group respectively. Data analysed longitudinally 
found a reduction in quality of life reported by 64% of men in the watchful waiting group and 
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61% of the radical prostatectomy group (p<0.0001 for both groups for difference between 
first and second follow up). 
 
Four studies, reported no differences in overall quality of life scores for men undertaking 
watchful waiting (Katz & Rodriguez, 2007; Mols et al., 2006; Siston et al., 2003; Steineck et 
al., 2002). Mols et al. (2006) however found that men in watchful waiting, radiotherapy and 
hormone therapy scored significantly worse (P<0.001) on the physical subscale compared 
with patients in the radical prostatectomy group. Patients in the watchful waiting group 
scored significantly better on the psychological subscale than patients who received curative 
treatment (P<0.05). However, there were no significant differences between groups on the 
total quality of life scores. 
 
Anxiety and depression 
Anxiety and depression was assessed by nine studies included in the review. Six studies used 
the SF-36, and three studies utilised other measures. One study used both the SF-36 and 
another measure. 
 
SF-36 
The findings over time are reported for the mental health component of the SF-36 in Table 3.  
 
Insert Table 3. 
 
The majority of studies did not report any significant differences on the SF-36 over time and 
between treatment groups (Arredondo et al., 2004; Bacon, Giovannucci, Testa & Kawachi, 
2001; Couper et al., 2009; Litwin et al., 2002; Mols et al., 2006). One study (Galbraith, 
Ramirez & Pedro, 2001) found watchful waiting participants scored significantly lower on 
the mental health component summary score compared to men in other treatment groups. 
Watchful waiting participants had lower scores in mental health when compared to proton 
beam radiation (p=0.03) and mixed beam radiation (p=0.07) at one year. However, there was 
no significant decrease in scores in the watchful waiting group over time. By 18 months the 
watchful waiting participants’ scores had increased and there was no longer a difference 
between watchful waiting and other treatment groups.  
 
 
 
The Psychological Impact of Watchful Waiting on Men with Prostate Cancer 
29 
 
Other anxiety and depression measures 
Anxiety and depression was assessed using different measures by three studies included in 
the review, as shown in Table 4.  
 
Insert Table 4. 
 
When assessing levels of anxiety, Couper et al. (2009) found that men in the watchful waiting 
group had significantly better scores than men in hormone therapy at follow-up (P<0.05). 
When assessing depression, men in the watchful waiting group scored significantly better in 
comparison to the hormone therapy group at one to two year follow up (P<0.05). 
 
Steineck et al. (2002) used a number of questionnaires to measure aspects of anxiety and 
depression. There were no significant differences between groups, apart from men in the 
radical prostatectomy group whose scores were slightly lower. Continuing from Steineck et 
al.’s (2002) analysis of the SPCG-4 data, Johansson et al. (2011) found when comparing 
anxiety symptoms between watchful waiting participants and a control group, a significant 
result was found (relative risk=1.42; 95% confidence interval, 1.07-1.88).  Depressed mood 
was reported by similar proportions of men in all groups. 
 
Sexual bother 
Sexual problems in men in the watchful waiting group were assessed by eight studies. Four 
studies used the UCLA, and five studies used other measures. One of these studies used both 
the UCLA and another measure. 
 
UCLA 
Sexual bother from the UCLA over time is reported in Table 5.  
 
Insert Table 5. 
 
Bacon et al. (2001) found sexual bother scores were significantly better for watchful waiting 
patients compared with radical prostatectomy (p<0.05). Similarly, Penson et al. (2003) found 
at two year follow up, men in the watchful waiting group reported less sexual bother than 
other treatment groups, although this was a non-significant difference. 
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In contrast, non-significant decreases in scores were found by two studies. Arredondo et al. 
(2004) found a clear age effect and larger time trend for the watchful waiting participants 
when considering both sexual bother, meaning that the decrease after diagnosis was greater 
than expected from ageing alone. They also reported that the decrease in bother appeared to 
be slightly steeper in the first two years compared with subsequent years. Lubeck et al. 
(1999) reported no significant differences in scores in the watchful waiting participants over 
time, however there was a non-significant decrease in scores between year one and year two.  
 
Other sexual problem measures 
Four other measures of sexual problems were utilised by five studies. Often there were 
multiple questions related to sexual problems, therefore results associated to distress related 
to sexual problems are reported in Table 6.  
 
Insert Table 6. 
 
Bacon et al. (2001) found statistically significantly better scores (p<0.05) for watchful 
waiting participants when compared to radical prostatectomy patients at one to two years. 
Furthermore, Galbraith, Ramirez & Pedro (2001) found at six months, surgery patients 
reported more sexual symptoms than the men in watchful waiting (p=0.004). For watchful 
waiting patients, scores remained similar over the 18 month period. 
 
At one to two years, Steineck et al. (2002) found that the men in the watchful waiting group 
reported significantly less moderate or great distress compared to men in the radical 
prostatectomy group (relative risk 1.4; 95% confidence interval, 1.1-1.8). A median of 12.2 
years later, Johansson et al. (2011) found no significant differences between groups.  
 
Qualitative Findings 
 
The qualitative studies (Bailey, Wallace & Mishel, 2007; Hedestig, Sandman & Widmark, 
2003) identified the experiences and meaning of being a patient with prostate cancer 
undergoing watchful waiting. Thematic analysis of both studies revealed two themes. 
 
Theme 1: An uncertain treatment decision 
The decision making process around whether or not to undertake watchful waiting was 
characterised by uncertainty and worry. Men questioned whether or not to request a second 
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opinion after watchful waiting was recommended, worrying that this would add to their 
conflict about their decision. Some men also spoke about gathering further information that 
would help reduce their conflict around the choice, whereas other men chose not to be 
informed and allow other people to make the decision for them. 
 
The decision to undertake watchful waiting was followed by an “emotional aftermath”, 
characterised by uncertainty, fear and worry. Men described living with a constant threat, 
being uncertain about whether the disease would shorten their lives, with the knowledge that 
it could “strike” at any time. Many men who had no physical discomfort reported that they 
found it difficult to believe the cancer existed. Lack of symptoms also meant that there were 
very few bodily signals to help monitor progression of the disease. Without markers to 
indicate disease progression, some men went on to attribute usual physical changes to disease 
progression. 
 
Theme 2: Coping with uncertainty 
The men spoke about a number of ways in which they coped and adjusted to living with an 
uncertain decision choice with an uncertain future. Men made various lifestyle changes, 
including increasing their social activities, throwing themselves into work or focussing on 
self-care. Some men tried to deny the cancer by trying to set the threat aside, whilst other 
men attempted to redefine or minimise the threat. A number of reasons were developed by 
the men to support their treatment choice, such as being healthy all their lives, infrequently 
relying on doctors in the past, other treatment options having poor outcomes and fears that 
aggressive surgery could seriously affect their lives. Men in both studies highlighted the 
importance of a trusting relationship with their physicians, which allowed them to feel safe, 
secure and confident in their treatment decision.  
 
Summary of Results 
 
In the 12 quantitative studies included within the review, watchful waiting was occasionally 
found to significantly lower men’s quality of life, and significantly worsen feelings of anxiety 
and depression, both over time and compared to other treatment groups. However, men in 
watchful waiting were often reported to have similar or better scores on sexual problem 
measures compared to other treatment groups. Additionally, improvements in anxiety and 
depression scores were found when men in the watchful waiting group were compared to 
men in the hormone therapy treatment group. Longitudinally, only one study (Johansson et 
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al., 2011) found a significant decrease in scores; a reduction in quality of life scores over time 
and poorer anxiety scores compared to men in the population based control group. Thematic 
analysis of two qualitative studies suggested that uncertainty played a key role in the 
treatment decision making process, how the future was viewed and led men to different 
coping strategies. Therefore, it is proposed that men initially experience uncertainty around 
the treatment decision, which negatively impacts on their wellbeing. However, over time, 
men appear to adjust to living with uncertainty, employing a number of coping strategies 
which means they have generally similar outcomes to men in other treatment groups.  
 
Conclusion 
 
The 14 studies included in the review suggest that watchful waiting may affect certain aspects 
of psychological wellbeing, although data is mixed. 
 
The majority of studies found no significant differences between quality of life in men 
undergoing watchful waiting compared to men in other treatment groups (Katz & Rodriguez, 
2007; Mols et al., 2006; Siston et al., 2003; Steineck et al., 2002). In contrast, Galbraith et al. 
(2001) found reductions in aspects of quality of life in men undergoing watchful waiting both 
compared to men in other treatment groups, and over time. Longitudinally, reduction in 
quality of life was found in men undergoing watchful waiting, although this was similar to 
men undergoing radical prostatectomy (Johansson et al., 2011).  
 
Two studies reported a statistically significant worsening in anxiety and depression scores for 
men in the watchful waiting group when compared with other treatment groups, however no 
significant changes were found when watchful waiting scores were compared over time. 
These were found at up to one year (Galbraith, Ramirez & Pedro, 2001) and at a median of 
12.2 years (Johansson et al., 2011). Conversely, significantly better scores were found at two 
time points (at diagnosis and approximately one year later) when men undertaking watchful 
waiting were compared to men on hormone therapy (Couper et al., 2009). 
 
Two studies found significantly improved sexual bother scores, between one to two years, 
when men in the watchful waiting group were compared to men in other treatment groups 
(Bacon et al, 2001; Steineck et al, 2002). No significant deteriorations in sexual bother or 
distress were found over time for men undertaking watchful waiting (Arredondo et al., 2004; 
Johansson et al., 2011; Lubeck et al., 1999; Penson et al., 2003; Siston et al., 2003).  
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The results from the qualitative studies suggest that men undertaking watchful waiting 
experience levels of uncertainty that permeate into many aspects of their lives (Bailey et al., 
2007; Hedestig et al., 2003). This was evident in both the decision making process, and when 
the decision had been made. Men, who had made the decision to undertake watchful waiting 
as their treatment option, reported living every day with the knowledge that they had cancer 
in their body. Lack of symptoms meant that men found it difficult to monitor their own 
disease progression and as a result often misattributed physical changes, leading men to 
employ a number of coping strategies to manage the uncertainty around both the treatment 
decision they had made, and the uncertain future they faced in terms of disease progression. 
The physician appeared to play a key role in helping the men trust and come to terms with the 
decision.  
 
Uncertainty has been shown to be a major stressor for patients coping with life threatening 
diseases and can affect quality of life (Padilla, Mishel & Grant, 1992). The mixed evidence as 
to the psychological effects of watchful waiting on men with prostate cancer might be 
explained in part by the uncertainty that appears to play a role in both the decision making 
process, and the ongoing experience of living with this option (Bailey et al., 2007; Hedestig 
et al., 2003). The ‘uncertainty in illness model’ (Mishel, 1988) has been proposed as a 
framework for viewing watchful waiting (Wallace, 2003). The uncertainty when diagnosed 
with a life threatening illness, regarding progression of symptoms and disease, can lead to 
uncertainty about wider life issues and ability to achieve valued goals. However, patients may 
then use the uncertainty to reorganise and recreate their life view. Wallace (2003) used this 
framework for understanding the impact of being diagnosed with prostate cancer, finding that 
as uncertainty and the perception of danger increased, quality of life decreased. A significant 
amount of variance (60%) in quality of life in their sample was explained by the combination 
of both uncertainty and danger perception.  
 
With this in mind, it is possible that the variability in results on psychological wellbeing 
reported in this review may be accounted for, to some extent, by the differences in levels of 
uncertainty and danger perception experienced by the men. The qualitative research 
suggested a number of factors that affect feelings of uncertainty, specifically around 
questioning whether they had made the right treatment choice (Bailey et al., 2007; Hedestig 
et al., 2003). Indeed, choosing watchful waiting appeared initially more likely to negatively 
impact on psychological wellbeing, which might be the result of uncertainty around not 
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receiving an active treatment. However, as men adjusted to watchful waiting over time, their 
psychological outcomes became generally similar to men in other treatment groups. 
 
Interestingly, Katz and Rodriquez (2007) proposed that no adverse effects of watchful 
waiting on quality of life were found in their study as patients were told during the 
educational process that watchful waiting was as acceptable a choice as the curative 
treatments offered. In addition, based on Mishel’s (1988) ‘uncertainty in illness model’, 
Bailey, Mishel, Belyea, Stewart & Mohler (2004) conducted an intervention study with men 
undertaking watchful waiting for prostate cancer and found that men who received the 
treatment came to see their lives in a new light, had a reduction in depressive symptoms, and 
reported increased quality of life. 
 
This review does however have several limitations. There is a high degree of heterogeneity in 
regards to study design, measures and data collected, which complicated the comparison and 
synthesis of study results, prohibiting a formal meta-analysis. Indeed, a recent Cochrane 
review (Hegarty et al., 2010)  found just two randomised control trials comparing watchful 
waiting and radical prostatectomy, one of which was judged to be of poor quality. The quality 
assessment found 13 of the studies were of good quality (ranging from 75% to 100% criteria 
met) and one study was of medium quality (50% criteria met). Just two of these studies were 
qualitative, meaning the thematic analysis was limited. 
 
More consistent research is required within this field, with agreed measures and design, 
including lengthy follow-up. Further data will firm up the evidence, so that men with prostate 
cancer can be better informed about their options. A lack of narrative views of the men 
actually undertaking watchful waiting must be addressed by future research. This would 
allow a greater understanding of the psychological impact of watchful waiting, and different 
coping strategies men employ to come to terms with their decision and an uncertain future. 
Whilst one promising interventional study has already been conducted (Bailey et al., 2004), 
further evidence is required to validate this finding and other intervention options should also 
be explored. The qualitative research suggested that men appreciated speaking to other men 
undertaking watchful waiting and often managed uncertainty through gathering information, 
which could indicate that a psycho-educational group might be helpful, and a potential 
direction for future research. 
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When physicians are aware of the psychological impact of watchful waiting they will be 
better able to advise, educate and support men considering watchful waiting as a treatment 
option for prostate cancer. The relationship between the men undertaking watchful waiting 
and their physician has been shown in the qualitative research to be very important in feeling 
safe and secure in the treatment decision making process. As a result, physicians must be well 
informed regarding the psychological, as well as the physical, effects of the different 
treatment options to maintain the men’s trust which will ultimately help the men manage and 
cope with uncertainty. Accurate information should be conveyed around the likely trajectory 
of psychological symptoms such as anxiety and depression, so that men can make an 
informed decision based on both survival rates and future quality of life.  
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Figure 1: Diagram to illustrate study selection 
 
 
 
 
 
 
 
 
 
 
  
675 studies initially identified 
from preliminary PsychInfo, 
PubMed and Web of 
Knowledge searches. 
46 full text articles assessed 
for eligibility based on 
selection criteria. 
14 studies included in the 
review (12 quantitative, two 
qualitative). 
32 studies excluded due to 
not meeting inclusion 
criteria. 
629 records excluded due to 
inclusion criteria and 
duplication. 
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Table 1: Findings of the included studies 
Study Quality 
Rating 
Design Questionnaires/ 
Measures Included in 
the Review 
Sample 
Characteristics 
N=number of 
participants (mean 
age) 
Major findings 
Quantitative 
Arredondo et 
al. (2004) 
***  Participants drawn 
from CaPSURE 
database. 
 Men completed 
between one and 16 
questionnaires over a 
five year period. 
 SF-36 
 UCLA 
 WW – N=310 (74.7)  Significant deterioration in seven 
domains of the SF-36 and four of the 
UCLA scales.  
 However mental health and mental 
component summary scores showed 
no difference over time.  
Bacon et al. 
(2001) 
****  Participants from the 
Health Professionals 
Follow-up Study 
(ongoing cohort 
study). 
 Cross sectional 
analysis. 
 Included a subgroup 
 SF-36 
 UCLA 
 Cancer Rehabilitation 
Evaluation System 
Short Form 
 WW – n=31 (75) 
 RP – n=421 (68) 
 ER – n=221 (75) 
 B – n=69 (71) 
 HT – n=33 (78) 
 Other – n=67 (76) 
 WW, ER and HT groups had lower 
HRQoL scores in multiple domains 
compared to RP patients. 
 WW patients had significantly better 
scores, on sexual problems, marital 
interaction, and cancer specific 
HRQoL compared to other groups.  
 No significant differences over time 
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who were followed 
prospectively. 
on mental health domains. 
Couper et al. 
(2009) 
***  Participants were 
consecutive attendees 
at participating clinics 
in public hospitals 
(2001-2005). 
 Completed self-report 
questionnaires before 
or soon after initiating 
treatment (T1), and 
again 12 months later 
(T2). 
 Brief Symptom 
Inventory 
 SF-36 
 WW – T1 n=61, T2 
n=55 
 RP – T1 n=38, T2 
n=33 
 HT – T1 n=56, T2 
n=51 
 OET – T1 n=38, T2 
n=33 
 At T1, the three active treatment 
groups all reported greater 
dysfunction compared with the WW 
group.  
 At T2, the RP and OET groups did 
not differ from the WW group on 
either HRQoL or psychological 
status. The HT group reported 
significantly worse HRQoL and 
greater psychological distress 
compared with the WW group. 
Galbraith et al. 
(2001) 
 
****  Men were enrolled in 
the study at initiation 
of treatment. 
 Questionnaires were 
completed at 
enrolment and at six, 
12 and 18 months. 
 Quality of Life Index 
 Southwest Oncology 
Group Prostate 
Treatment Specific 
Symptoms Measure – 
treatment related 
symptoms 
 WW – n=30 (73) 
 S – n=59 (65) 
 CR – n=25 (71) 
 PB – n=24 (68) 
 MB – n=47 (69) 
 At 12 months MB and PB men 
reported significantly better HRQoL 
than WW men.  
 Men in WW reported poorer health 
status throughout the study in 
physical, emotional, mental and 
overall general health. 
Johansson et 
al. (2011) 
****  Part of SPCG-4 trial. 
 Cross sectional data 
 Study specific 
questionnaire.  
 WW – n=167  
 RP – n=182  
 High self-assessed quality of life was 
reported at four years by 69% and at 
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analysed at a median 
of 4.1 years and 12.2 
years after 
randomisation. 
 Longitudinal analysis 
conducted for data 
available at two time 
points, with a median 
of 3.7 years and 13.4 
years after 
randomisation. 
 Population based 
control – T2 n=208  
Longitudinal analysis 
 WW – n=81  
 RP – n=85  
12 years 24% in the WW group, and 
by 70% and 36% in the RP group. 
 A reduction in quality of life during 
longitudinal follow-up was reported 
by similar numbers of men in WW 
and RP. 
Katz & 
Rodriguez 
(2007) 
**  Questionnaire 
administered after 
diagnosis but before 
treatment, and re-
administered at follow-
up one to two years 
later. 
 A modiﬁed American 
Urological Association 
Symptom Score. 
 WW – n=20 (68.2) 
 CT – n=41 (64.6) 
 WW patients maintained their 
HRQoL and was similar to those 
undergoing CT. 
Litwin et al. 
(2002) 
****  Participants drawn 
from CaPSURE 
database. 
 Questionnaires were 
 SF-36  WW – n=66 (71.3) 
 RP – n=282 (62.1) 
 PI – n=104 (70.8) 
 Gaps between mental health scores 
grew wider among the treatment 
groups over time, with PI patients 
performing the best, RP patients 
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completed at least 
twice by each 
participant during the 
two year follow up 
period. 
performing the worst, and WW 
patients falling in between.  
 
Lubeck et al. 
(1999) 
***  Participants drawn 
from CaPSURE 
database. 
 Questionnaires 
completed at study 
entry and quarterly 
thereafter through to 
two years. 
 SF-36 
 UCLA 
 WW/Observation 
(term used 
interchangeably) – 
n=87 (72.1) 
 RP – n=351 (62.0) 
 R – n=75 (70.2) 
 HT – n=179 (72.4) 
 Men in WW had poorer HRQoL in 
the first year.  
 However, improvements in these 
scores during the first year were also 
observed. 
Mols et al. 
(2006) 
****  The population based 
Eindhoven Cancer 
Registry was used to 
select men who had 
been diagnosed with 
prostate cancer. 
 Questionnaires were 
sent five to ten years 
post diagnosis. 
 SF-36 
 Quality of Life-Cancer 
Survivors 
Questionnaire 
 WW – n=56 
 RP – n=193 
 R – n=263 
 HT – n=60 
 Patients who underwent RP had the 
best physical HRQoL, followed by 
patients who received WW and 
finally patients who received R. 
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Penson et al. 
(2003) 
****  Part of SEER 
programme. 
 Completed baseline 
questionnaires six to 
12 months after 
diagnosis, and at two 
years. 
 SF-36 
 UCLA 
 
 WW – n=379 
 RP – n=1070 
 R – n=533 
 HT – n=324 
 No statistically significant differences 
in general HRQoL outcomes between 
the treatment groups.  
 
Siston et al.  
(2003) 
****  Recruited from 
Veterans Affairs 
populations. 
 Questionnaires given 
before initiating 
treatment, and again at 
three and 12 months. 
 European Organization 
for Research and 
Treatment of Cancer 
Quality of Life 
Questionnaire. 
 WW – n=39  
 RP – n=29  
 R – n=30 
 Patients undergoing WW reported 
more sexual functioning problems 
pre-treatment than the rest of the 
study sample.  
 No significant changes over time in 
psychological items. 
Steineck et al. 
(2002) 
****  Part of SPCG-4 trial. 
 Follow-up study  
 Data collected at least 
12 months after 
surgery and 14 months 
after randomisation. 
 
 Study specific 
questionnaire. 
 Spielberger’s Trait 
measure from the 
State-Trait Anxiety 
Inventory. 
 Centre for 
Epidemiological 
 WW – n=160  
 RP – n=166  
 No difference between the two groups 
on the nine psychological variables. 
 Low or moderate psychological 
wellbeing and subjective quality of 
life was reported by similar numbers 
of WW and RP men.  
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Studies measure of 
Depression. 
Qualitative 
Bailey et al. 
(2007) 
***  Interviewed men 
undertaking watchful 
waiting less than 12 
months after 
diagnosis. 
 The results were 
analysed using the 
Mishel’s 
Reconceptualised 
Uncertainty in Illness 
model. 
-  N=10   Domains of uncertainty, appraisal of 
danger and appraisal of opportunity 
were identified and discussed.  
 
Hedestig et al. 
(2003) 
****  The text was analysed 
using a 
phenomenologic 
hermeneutic approach. 
-  N=7   Men described living with a constant 
threat, whilst being uncertain about 
the effects of the disease the length 
of their life.  
 They believed that the disease had 
changed their lives, and their 
manhood was restricted by sexual 
dysfunctions and described as a 
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burden.  
Scores vary from ** (50%) – two criteria met, to **** (100%) – all criteria met. 
HRQoL–Health related quality of life; CaPSURE–Cancer of the Prostate Strategic Urologic Research Endeavour; SEER–National Cancer 
Institute’s Surveillance, Epidemiology and End Results registries; SPCG-4–Scandinavian Prostate Cancer Group Study Number 4 
T1-Time 1; T2-Time 2 
Measures: SF-36–Medical Outcomes Study Short Form-36; UCLA–University of California at Los Angeles Prostate Cancer Quality of Life 
Index 
Treatment groups: B–Brachytherapy; CR–Conventional Radiation; CT–Curative therapy; ER–External Radiation; HT–Hormone therapy; MB–
Mixed beam radiation; OET–other early treatment; PB–Proton beam radiation; PI–Pelvic Irradiation; R–Radiotherapy; RP–Radical 
prostatectomy; S–Surgery; WW–Watchful waiting 
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Key for Tables 2, 3, 4, 5 and 6 
 – data collected during this time point 
Red – significantly poorer scores in comparison with other treatment groups/significant deterioration in scores over time. 
Yellow – no significant difference between groups/no significant changes over time.  
Green – significantly better scores in comparison with other groups/significant improvement in scores over time. 
B–Brachytherapy; CR–Conventional Radiation; CT–Curative therapy; ER–External Radiation; HT–Hormone therapy; MB–Mixed beam 
radiation; OET–other early treatment; PB–Proton beam radiation; PI–Pelvic Irradiation; R–Radiotherapy; RP–Radical prostatectomy; S–
Surgery; WW–Watchful waiting 
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Table 2: Quality of life over time 
Study Questionnaire Comparison 
group 
Pre-
treatment/ at 
diagnosis 
Up to 1 year 1 to 2 years 3 to 5 years 5 to 10 years 7 to 17 years 
Galbraith et 
al. (2001) 
Quality of Life 
Index 
 
WW 
compared 
with S, CR, 
PB, MB 
    
WW scores 
poorer than 
MB & PB 
     
WW over 
time 
    
 
  
 
   
Johansson 
et al. (2011) 
Study specific WW 
compared 
with RP 
        
 
WW over 
time 
        
WW scores 
deteriorated 
Katz & 
Rodriguez 
(2007) 
Modified 
American 
Urological 
Association 
Symptom Score 
WW 
compared 
with CT 
    
 
   
WW over 
time 
       
Mols et al. Quality of Life- WW        
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(2006) Cancer 
Survivors 
Questionnaire 
compared 
with RP, R, 
HT 
Siston et al. 
(2003) 
European 
Organization 
for Research 
and Treatment 
of Cancer 
Quality of Life 
Questionnaire. 
WW 
compared 
with RP, R 
         
WW over 
time 
         
Steineck et 
al. (2002) 
Study specific WW 
compared 
with RP 
       
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Table 3: Mental health component of SF-36 over time 
Study Comparison 
group 
Pre-
treatment/at 
diagnosis 
Up to 1 year 1 to 2 years 5 to 10 years 
Arredondo et 
al. (2004) 
WW over 
time 
        
Bacon et al. 
(2001) 
WW 
compared 
with RP 
      
WW over 
time 
      
Couper et al. 
(2009) 
WW 
compared 
with RP, HT, 
OET 
  
WW scores 
better than 
HT 
    
WW over 
time 
      
Galbraith et 
al. (2001) 
WW 
compared 
with S, CR, 
PB, MB 
    
WW scores 
poorer than 
MB & PB 
  
 
 
WW over        
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time  
Litwin et al. 
(2002) 
WW 
compared 
with RP, PI 
       
WW over 
time 
       
Mols et al. 
(2006) 
WW 
compared 
with RP, R, 
HT 
     
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Table 4: Anxiety and depression scale scores over time 
Study Questionnaire Subscale Comparison 
group 
Pre-
treatment/at 
diagnosis 
1 to 2 years 7 to 17 years 
Couper et 
al. (2009) 
Brief Symptom 
Inventory 
 
Anxiety WW 
compared to 
RP, HT, OET 
    
WW scores 
better than 
HT 
 
WW over 
time 
     
Depression WW 
compared to 
RP, HT, OET 
  
WW scores 
better than 
HT 
  
WW scores 
better than 
HT 
 
WW over 
time 
     
Johansson 
et al. (2011) 
Study specific Anxiety WW 
compared to 
RP, C 
    
WW scores 
poorer than C 
Depression WW 
compared to 
RP, C 
    
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Steineck et 
al. (2002) 
Study specific Anxiety WW 
compared 
with RP 
    
Depression WW 
compared 
with RP 
    
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Table 5: Sexual bother measured by UCLA over time 
 Comparison 
group 
Pre-
treatment/at 
diagnosis 
Up to 1 year 1 to 2 years 5 to 10 years 
Arredondo et 
al. (2004) 
WW over 
time 
        
Bacon et al. 
(2001) 
WW 
compared 
with RP 
    
WW scores 
better than 
RP 
 
Lubeck et al. 
(1999) 
WW over 
time 
       
Penson et al. 
(2003) 
WW 
compared 
with RP, R, 
HT 
     
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Table 6: Sexual problems scores over time 
 Questionnaire Comparison 
group 
Pre-
treatment/at 
diagnosis 
Up to 1 year 1 to 2 years 7 to 17 years 
Bacon et al. 
(2001) 
Cancer 
Rehabilitation 
Evaluation 
System Short 
Form 
WW 
compared 
with RP 
    
WW scores 
better than 
RP 
 
Galbraith et 
al.  (2001) 
Southwest 
Oncology 
Group Prostate 
Treatment 
Specific 
Symptoms 
Measure 
WW 
compared 
with S, CR, 
PB, MB 
    
WW scores 
better than S 
   
WW over 
time 
       
Johansson 
et al. (2011) 
Study specific WW 
compared 
with RP, C 
     
Siston et al. 
(2003) 
European 
Organization 
for Research 
WW 
compared 
with RP, R 
    
 
   
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and Treatment 
of Cancer 
Quality of Life 
Questionnaire. 
WW over 
time 
    
 
  
 
Steineck et 
al. (2002) 
Study specific WW 
compared 
with RP 
    
WW scores 
better than 
RP 
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Abstract 
 
Mild Cognitive Impairment (MCI) is a heterogeneous clinical state whereby assessed 
cognitive changes over time may progress to dementia, remain stable or revert to back to 
normal. This study aimed to identify, through discourse analysis, how people with a 
diagnosis of MCI used language in order to reveal the societal views and shared meanings of 
the diagnosis, and the positions taken by people. Seven people with MCI were interviewed, 
and three discourses emerged during analysis. One of the discourses revealed was ‘Not 
Knowing’ about MCI. Furthermore, in the absence of a coherent discourse related to MCI, 
participants went on to position themselves between a more familiar discourse; ‘Knowing’ 
about ageing and dying and ‘Not Wanting to Know’ about dementia. Clinicians must 
consider how information is presented to people about MCI, including where MCI is 
positioned in respect to normal ageing and dementia.  
 
Keywords: Ageing, Dementia, Discourse, Mild Cognitive Impairment. 
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Introduction 
 
People are given a label of Mild Cognitive Impairment (MCI), if they are found to show a 
mild decline in either single or multiple cognitive domains, such as memory, attention, 
visuospatial or executive functioning abilities. Their global cognitive abilities remain intact, 
alongside their ability to undertake activities of daily living, unlike when given a diagnosis 
of dementia (Gauthier et al., 2006). However, MCI is a label that describes a heterogeneous 
clinical presentation, and the cognitive changes over time may progress to a dementia, 
remain stable or improve to a previous state of functioning. The percentage of people who 
develop a dementia after being given a diagnosis of MCI is thought to vary from 2% to 31% 
(Bruscoli & Lovestone, 2004).  
  
The term MCI was originally created for research purposes and is relatively unknown to the 
general public. Therefore, a lack of societal knowledge around MCI may impact on the 
meaning assigned to it by people (Dale, Hougham, Hill & Sachs, 2006). Limited 
understanding of a diagnosis can cause uncertainty, and people given the diagnosis of MCI 
are at risk of either over or under estimating the significance of it (Lingler et al., 2006). Thus 
far the majority of research into MCI has focussed on characterising the rates, predictors and 
potential modifiers of progression to specific dementia types (Petersen et al., 2001). 
 
In order to improve understanding of the effects of being given a diagnosis of MCI, research 
is beginning to focus on the narrative accounts of these individuals. Primarily negative 
emotions have been associated with being given a diagnosis of MCI, including sadness, 
frustration, reduction in self-confidence and embarrassment, whilst people have also 
expressed uncertainty around the nature of the diagnosis (Joosten-Weyn Banningh, 
Vernooij‐Dassen, Rikkert & Teunisse, 2008; Lingler et al., 2006; Roberts & Clare, 2013). 
Furthermore, a number of the qualitative studies have found that people with MCI are likely 
to attribute their problems to various causes, such as normal ageing, approaching dementia 
or somatic causes (Beard & Neary, 2013; Berg, Wallin, Nordlund & Johansson, 2012; 
Corner & Bond, 2006; Joosten-Weyn Banningh et al., 2008; Lingler et al., 2006). As a 
result, various coping strategies have been employed by people with MCI, with conflicting 
evidence as to whether problem and emotion focussed coping strategies are used more often 
than dysfunctional coping strategies (McIlavane, Popa, Robinson, Houseweart & Haley, 
2008; Roberts & Clare, 2013).  
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The exploration of the narrative accounts of individuals with a diagnosis of MCI has so far 
primarily focussed on the lived experience of MCI, which has increased understanding of 
the diagnosis at an individual and personal level. However, with limited knowledge about 
MCI in the public domain, there has been little focus on how this diagnosis is constructed at 
a societal and communal level, despite the social consequences and implications of 
predicting a possible diagnosis of dementia, potentially a long time before functional 
symptoms are experienced. Given that a diagnosis of any ‘memory problem’ can create 
social problems for affected individuals, making sense of and understanding the MCI illness 
identity is of great social significance (Beard & Neary, 2013).  
 
Through interviewing people with a diagnosis of MCI, this study aims to identify how 
people draw on societal shared meanings of MCI, as expressed in their use of language, thus 
increasing the understanding of how they position themselves in respect to their previously 
reported attributions of the diagnosis to aspects like dementia and ageing. Understanding the 
different discourses that people with MCI draw on and move between, might shape the 
understanding of how they construct the diagnosis. 
 
Conceptual Background 
 
A discourse is the narrative of a phenomenon as it has become shaped through shared 
meanings, norms and values, personal and group identities and negotiated interactions 
(Harper, 2012). Discourse analysis attempts to understand how people use language to 
construct versions of the social world (Burck, 2005). It does not aim to capture participants’ 
authentic meanings, intentions or experiences, but rather analyses language as social text, 
whereby in different speech situations and social contexts the individual draws upon a 
variety of linguistic resources (Potter & Wetherell, 1987; Talja, 1999). Language is 
considered a means of constructing, rather than mirroring, reality (Harper & Thompson, 
2011).  
 
When language is studied for its discourses, it is studied for its functions, both intended and 
unintended (Wetherell & Potter, 1988). Language reflects a form of social action whereby 
involvement in social interactions is managed by people through discursive activities, such 
as to justify, categorise, rationalise, explain, attribute, name and blame. In addition, people 
can use language to position themselves in a variety of ways. Different positions entail 
different degrees of accountability and can have a variety of functions, such as to distance 
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the speaker or to authoritatively endow what is being said (Harper & Thompson, 2011). All 
of these functions of language are used by people within particular contexts to achieve social 
and interpersonal objectives (Willig, 2013). 
 
Method 
 
Participants 
 
Seven people participated in the study. All were British, Caucasian and English was their 
first language. Just one participant spoke Welsh as a second language. Demographic data 
were recorded (Table 1; Appendix 2.1). 
 
Table 1: Demographic details of participants 
Participant* Age Marital status Highest level of education 
Gwen 78 Married Secondary school  
Clive 76 Married College 
Andrew 79 Married College  
Jack 72 Married Secondary school 
Margaret 77 Married University 
Simon 61 Married College 
William 60 Divorced College 
*All participants’ details and accounts are presented under a pseudonym and any identifying 
details have been removed, anonymised or generalised in order to preserve confidentiality.  
 
Procedure 
 
Bangor University School of Psychology, and NHS Research Ethics Committee and 
Research and Development approval was sought and granted. Clinicians from memory 
clinics across North Wales, where people are diagnosed with MCI, identified potential 
participants who fitted the inclusion and exclusion criteria (Appendix 2.2):  
 
 A diagnosis of MCI which has been confirmed by the Memory Clinic 
multi-disciplinary team,   
 The ability to fluently communicate verbally in English, 
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 The ability to give informed consent to take part in the study,   
 Aged 55 or over.   
 No co-morbid diagnosis (including a mental health diagnosis or physical health 
diagnosis), 
 No language difficulties (such as aphasia). 
 
In order to maintain confidentiality, clinicians initially contacted the potential participant to 
gain consent to send out a participant information pack (Appendix 2.3) with further details 
of the study and an invitation to contact the first author for further information. If they were 
interested, the potential participant sent a reply slip to the first author with their contact 
details. Before initiating the interview, informed consent was gained (Appendix 2.4). 
 
The first author conducted all interviews, either at the participant’s home or at the 
participant’s local NHS memory clinic. An outline schedule (Appendix 2.5) was developed 
based on existing literature, with questions moving from externalising, to establish the 
participants’ knowledge and understanding of the MCI term, to personalising, to determine 
personal meaning and the development of their ideas, and specifying, to explore the 
perceived advantages and disadvantages of the diagnosis. Further prompting occurred in an 
exploitative manner in order to encourage participants to elaborate on their views in a 
reasonably naturalistic conversation (Potter & Wetherell, 1987). Interviews lasted between 
44 and 52 minutes. Participants were given an information sheet at the end which detailed 
sources of support, should they need it (Appendix 2.6). The consent form and all 
information sheets were provided in both English and Welsh. 
 
Data Analysis 
 
Interviews were transcribed by the first author and checked for accuracy. Vocal tones, 
pauses and hesitations were later included: 
 
Bold: said with emphasis/louder voice. Italics: said softer/quieter/under breath.  
!: vocal intonation became higher. 
(.) noticeable breathing space, (..) 3-5 second pause, (…) more than 5 second pause. 
 
There is no widely agreed method for discourse analysis, however the analysis in this study 
was based on Potter and Wetherall’s (1987) procedures. The data was first thematically 
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coded to help “squeeze an unwieldy body of discourse into manageable chunks” (Potter & 
Wetherall, 1987, p.167). At this stage, coding of the analysis had a pragmatic intent, rather 
than analytic. The purpose was to organise data into broad themes to produce sets of 
instances of occurrence that could later be analysed. The following initial themes emerged 
from the data based on recurring words, phrases and ideas: ageing, death/dying, dementia, 
expertise, hierarchy of illness and MCI. This formed a basis for the more detailed discourse 
analysis, where further close reading of coded data sets took place.  
 
The analysis of the data focussed on the variation and similarities across the data sets. 
Following Potter and Wetherell (1987), data was examined with two questions in mind: 
“Why am I reading the passage in this way? What features produce this reading?” (p.168). 
Attention was paid as to how certain phrases or terms were used, the context of and reason 
for their use, the intended or unintended function or purpose of their use, and how language 
influenced positioning of the participant (Appendix 2.7: Sample interview transcript and 
analysis). 
 
Findings 
 
Three discourses emerged during the analysis of the interview material. The first discourse 
revealed was participants ‘Not Knowing’ about MCI. As a result, participants drew on and 
moved between two other, more familiar discourses; ‘Knowing’ about ageing and dying, 
and ‘Not Wanting to Know’ about dementia (Appendix 2.8: Further transcript examples 
illustrating the discourses).   
 
Not Knowing 
 
When participants were invited to describe MCI, their speech was characterised by pauses, 
hesitations, repetitions and changes in tone.  
 
Margaret: (.) I think (.) it’s ur (.) the way it’s affected me is that (.) I’m not 
remembering, facts from (.) from the present. 
Clive: I don’t really know, but I know it’s to do with my, memory loss, short memory, 
short term memory loss. 
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These features of the participant’s speech caused the content to feel disjointed. Margaret 
paused frequently, which suggested an underlying uncertainty about what to say and how to 
say it, whilst speaking the occasional word quietly appeared to reflect an uncertainty about 
what MCI meant. In contrast, Clive was more fluent when he described MCI but he repeated 
certain words, as if he wanted to ensure that he got the phrasing correct. The repetition 
appeared to show how unfamiliar he seemed to be with the wording. Similarly, the term 
“mild cognitive impairment” was infrequently used by participants, and when it was used, it 
was with hesitation and uncertainty. 
 
Simon: …And all this, all this (.) mild cognitive, you know disorder… 
 
More often, participants used different terms to explain their difficulties, such as “stroke” 
(Gwen) and “bang on me head” (Simon), which has previously been reflected in the 
narrative accounts of people with a MCI diagnosis (Lingler et al., 2006; Roberts & Clare, 
2013).  Lack of use of the MCI term could suggest that people with the diagnosis were not 
able to draw on a particular discourse related to MCI, either because they were not familiar 
with it, or there was no coherent discourse available. 
 
This lack of knowledge and lack of discourse about MCI appeared to be related to whether 
they had spoken about MCI with family or friends. When asked about this, the participants 
appeared to disengage from the conversation, replying with short answers. The majority of 
participants reported that they had not spoken about the MCI diagnosis with their family or 
friends in any detail, almost dismissing it. 
 
Simon: Don’t bother really. [No] No.  
 
If the participants had shared the MCI diagnosis, it was only briefly touched upon, as 
participants suggested that they and other people had “other interesting things to talk about” 
(Margaret). MCI had been constructed by the participants as a diagnosis which appeared to 
be of little interest to them and others, and thus appeared to have been given little space in 
their lives or within their social identity.  In contrast, one participant, William, had shared 
the MCI diagnosis with his friends and explained to them that it was affecting his memory.  
 
William: All my friends know about it. [Right] They all make allowances for me, 
they’re very good like that. 
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“All” of William’s friends knew about the MCI diagnosis, although he did not give “it” a 
name. However, the use of “they” versus “me” suggested a sense of being separate and 
different from his group of friends. His friends now “make allowances” for him, implying 
that he was treated differently by his peers, who might now see him as ‘damaged goods’. He 
accepted this and appeared to view this positively, rather than being resistant to the 
allowances made, stating that his friends were “good like that”. William echoed a societal 
view and discourse that making “allowances” for people who were cognitive impaired or 
disabled was a ‘social good’, something that ought to be done and is viewed as socially 
desirable and positive. The phrasing William used suggested that the diagnosis meant 
impairment and had not only changed how he viewed himself, but also how he was viewed 
by his friends.  
 
The participants’ lack of knowledge about MCI often caused them to query who the experts 
were – who had the knowledge about MCI? The participants put many people in the position 
of expert throughout the interviews, including the interviewer.  
 
Clive: … And then I found out really what, what I’ve got and what that means, I think.  
Interviewer: And what do you think that that means? 
Clive: It means I’m struggling with memory. [Yeah] I think that’s what it does mean, 
doesn’t it? [Yeah] Or is it something more complicated? 
 
Clive initially took a hesitant expert role, indicating that he knew what the MCI diagnosis 
meant. When asked further about this by the interviewer, he began to answer with certainty 
and without hesitation. However, he then became quickly less certain, and put the 
interviewer in the position of expert by asking the interviewer a question. The participants 
looked towards other people, including physicians, in perceived ‘expert’ roles. However, 
they responded with an intuitive knowledge about what was wrong with them, in an attempt 
to strongly reaffirm their own expert status. 
 
Jack: And the diagnosis was just a confirmation of what I already suspected. 
Margaret: Well in a sense it was a bit of a relief cos I already knew that it was that I 
was suffering from it. 
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Jack and Margaret suggested that they knew that something was different and something had 
changed, even though they were not able to specify what “it” was or use the MCI 
terminology. This was said with certainty, without pause or hesitation, and was reflected by 
many of the other participants. Despite the participant’s uncertainty and lack of knowledge 
about MCI, they viewed themselves as the expert when monitoring their own cognitive 
changes. 
 
Participants held no coherent discourse around MCI. In this seemingly confused position, 
participants began to turn to other discourses in order to assist them with the construction of 
the diagnosis. 
 
Knowing – Ageing and Dying 
 
In the absence of a coherent discourse, around a diagnosis given to them by experts in  a 
memory clinic, participants turned to a more familiar discourse to help them ascertain their 
positioning – that of ambivalent ageing and certainty of death. This appeared to be a 
discourse participants were familiar with and knowledgeable about. 
 
Margaret: It’s just this awful long haul down to (.) old age isn’t it and death (.) you 
sort of think how nice it would be if you could just sort of press a button and say right 
that’s it I’m going, and there’s a lot of that of course in, in the press isn’t there. [Yeah] 
When I was a lot younger I didn’t think along these lines. But now I’ve reached (.) this 
age (.) I suppose (.) I think about it quite a lot. 
 
When speaking about ageing and dying, participants were more fluent in their speech.  In 
contrast to pauses when talking about MCI, which suggested uncertainty and lack of 
discourse, pauses or hesitations when talking about ageing and dying appeared to serve a 
different function. As the content of speech was more fluent, pauses implied that these 
topics were difficult to talk about, showing the emotive but familiar nature of these 
discourses, particularly when talking about death and dying. In this passage, Margaret 
suggests that even (a chosen) death would be preferable to a slow cognitive decline. 
 
Participants put themselves in a variety of positions when talking about ageing. Use of 
pronouns allowed participants to either distance or associate themselves with the ageing 
process. As Margaret demonstrated above, she began by talking in the second person “you”, 
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thereby detached herself from the talk about death and implied assisted dying. She then later 
moved to talking in the first person “I”, personalising and taking ownership of what she had 
previously said.  
 
Participants moved between reluctantly identifying themselves as ageing and getting older to 
distancing themselves from being identified by others as an older person. 
 
Jack: …I just realise I’m not getting any younger, I’ve got to start slowing down a 
little bit. 
Gwen: …they were terrified of debt weren’t they. The older people. 
 
Jack used “I” to identify himself as ageing which gave him permission to slow down, 
whereas Gwen used “they” to distance herself from the older generation. It is “they” who 
were terrified, “the older people”, in a category of their own. Categorisation of old age was 
also mentioned by several participants. Gwen suggested there was no defining line. 
 
Gwen: She (Gwen’s sister) had a big party when she turned 80 and all that you know 
(.) it just crept up on me! (laughs) You know, I don’t think of myself as 80! 
 
Gwen’s exclamation, that turning 80 had “just crept up on” her, reflected a sudden 
realisation of an ageing process. Being 80 years old appeared to have conjured up an image 
of Gwen as to what an 80 year old woman should look and behave like, and she did not feel 
she fitted into this. However, other people might have already categorised and perceived her 
as old, based on her age alone, rather than on how she felt. In addition, Margaret described 
retiring and waking up one day as “plain old Mrs so and so, OAP”, suggesting that old age 
as an identity was defined by the absence of employment. Furthermore, retirement had 
rendered her “plain” and nameless, suggesting that as a result of her age and retiring, she 
was almost invisible, had no identity and likely little impact or relevance in society. Even 
when participants returned to a more familiar ageing discourse, the position given to them 
did not fit with their own perceptions of their social identity.  
 
Ageing and dying were emotionally difficult for participants to discuss, and in this context 
they tended to distance themselves from being seen as “getting older” (Gwen). However, 
participants appeared more comfortable with using this discourse to talk about the symptoms 
associated with MCI as an aspect of normal ageing.  
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Jack: …it wasn’t a serious matter it was just a mild (.) forgetfulness that (.) to my 
mind age related. 
 
As Jack stated, participants often viewed their difficulties as related to ageing, and therefore 
accepted by themselves and society as inevitable and not viewed as “serious”.  Forgetfulness 
in ageing was spoken about as a “common thing” (Margaret), “[j]ust that you’re getting old” 
(Gwen), and therefore viewed as something that was normal for an older person. As such, a 
diagnosis of MCI had limited impact and posed no major threat, apart from the challenges 
that were anticipated and expected in an ageing discourse.  
 
Participants viewed themselves as holding the expertise on ageing, regardless of whether or 
not they identified themselves as an older person. However, they felt they were often not 
heard. 
 
Andrew: I’m not a bloody idiot! [Yeah] And I tell them loud and clear. 
 
Andrew’s comment might refer to a perceived view of older people as “idiot[s]”, suggesting 
that they lacked capacity and intelligence. His need to speak loudly implied that older people 
were not listened to and ignored. Andrew tried to fight against this aspect of an ageing 
discourse, by asserting an alternative discourse of ageing which had to be said “loud and 
clear”. This appeared in contrast to Gwen who was resigned to her position as an older 
person, however both expressed a discourse in which older people were ignored and 
removed from society. 
 
Gwen: But ur (...) it’ll get sorted out, I’ll get put somewhere, shoved in a cupboard! 
(laughs) 
 
Here, Gwen implied that older people, especially when they have reached a certain stage in 
their lives and started to show impairments, were “put” or “shoved”, hidden away, like an 
object that was no longer considered useful or needed and needed to be kept out of sight. 
Despite laughing at the end of the sentence, this was something she was concerned about, 
highlighted by the pause near the start of the sentence, perhaps wondering whether or not to 
express this thought. In contrast, Margaret had a slightly different view of the future, and 
what it meant to age. 
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Margaret: And there’s a constant feeling of being at the end of my life now, I’m very 
aware that I’m 77, and that (.) ur I’ve got to really enjoy every single moment of 
what’s left, cos I’m, ha, happily married and I’ve got a lovely family, just keep 
thinking I’m going to have to leave them all one of these days, sooner rather than later. 
That comes into my everyday feelings. [Okay] A lot. [Yeah] Quite a lot. 
 
Margaret appeared to express an obligation “I’ve got to”, rather than a desire, for 
contentment and gratefulness in light of an impending death. Death was not overtly named 
but expressed as an euphemism, “I’m going to have to leave them all one of these days”. 
However, Margaret’s repeated use of “I” enabled her to position herself as someone with 
knowledge and wisdom about the future, without needing to explicitly name death. 
Furthermore, her emphasis of “[t]hat” suggested that it was in fact ageing and dying that 
were given more importance by her, rather than the impact of being diagnosed with MCI. 
 
Ambivalent ageing and certain death appeared to provide the participants with a well-
formed and well known discourse to draw upon. Although this discourse functioned as a 
legitimate way for participants to normalise and almost dismiss the diagnosis of MCI, 
integrating their symptoms as part of ageing and impending death, it also created the 
uncomfortable position of being viewed as limited use and not to be attended to. 
 
Not wanting to know – Dementia  
 
Ageing and dying, however, was not the only discourse drawn upon by the participants. As 
participants showed an awareness of the possibility that MCI could deteriorate, they went on 
to consider a discourse around dementia as applicable to them.  
 
Simon: Well I do worry if it gets worse. [Yeah] Urm (.) I wouldn’t want to end up like 
they say a cabbage (.) you need your faculties don’t you in life (.) urm (.) that’s (.) I 
try not to think about it really. [Okay] Cos you know (indecipherable). [Pardon?] Just 
hope it doesn’t go worse. [Yeah] (.) Just plod on. 
 
Again, speech was less fluent when talking about dementia, with frequent pauses, changes in 
tone, and short sentences. Similar to an ageing and dying discourse, the non-verbal features 
reflected that this was a difficult, sensitive topic, as illustrated by Simon, who tried “not to 
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think about it”, and found it difficult to consider a possible decline. He also suggested that 
one’s faculties were needed for living and that living with impaired cognitive ability would 
not be constituted as living. This echoed Margaret’s comments about preferring death over a 
life with slow cognitive decline. Although Simon did not name dementia explicitly, his use 
of wording, “cabbage”, suggested that he was referring to a dementia discourse.  
 
Margaret: And that awful word Alzheimer’s looming up.  
 
Margaret reflected how powerful labels, such as Alzheimer’s, could be and how the 
diagnosis itself could conjure socially constructed negative connotations and stigma. She 
described the diagnosis as an “awful word” and gave it a metaphorical life of its own, 
“looming up”, almost as though the word could threaten her own identity. The terms 
dementia and Alzheimer’s have become deeply value-laden words, which now elicit strong 
feelings, such as profound dread (Zeilig, 2014).  
 
A number of highly emotive words and phrases were used when participants’ drew upon a 
dementia discourse, such as “suffer” (Clive), “fool” (Clive, William), “awful affliction” 
(Clive), “cabbage” (Andrew, Simon), “lunacy” (Jack), “brain dead” (Jack), and “lost her” 
(Margaret). Some of the words and phrases were used by several participants, some of 
whom knew people who had been given a dementia diagnosis (Clive’s mother, Jack’s father, 
several of Margaret’s family members and her friend), suggesting a well-formed and 
familiar discourse which offered undesirable and unwanted positions. Participants also 
named the media as their prime source of information and holding the expertise around 
dementia. 
 
Margaret: There’s a lot being written about it, and I tend to read it if I see it in the, 
particularly in the newspapers you see, articles about it, I read those (.) but I try not to 
think about it too much. 
 
The media is viewed as influential in shaping discourses (Kirkman, 2006) and was seen as 
the expert by many of the participants. They referenced it as a source of knowledge, both 
about the effects of the condition and how to “stave it off” (Margaret) or “avoid it” 
(Margaret). 
 
 Participants struggled between the two available discourses – ageing and dying or dementia. 
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Margaret: And you sort of wonder, at what point, you know you’ve got Alzheimer’s 
rather than you know a bit of senile dementia, what where is the cut-off point.  
Interviewer: Yeah, what do you think the cut-off point is? 
Margaret: Well I don’t know, I don’t know really. (.) Now that would worry me, that 
would worry me very much. (.) I’m not sure (.) perhaps there isn’t a cut-off point, 
perhaps there’s a gradual deterioration, I don’t know. 
 
Margaret initially used “you” to detach herself from the statement when she wondered about 
the possibility of MCI converting to dementia. When asked specifically about what she 
thought, she gave a personal response, in the first person. However, responding in the first 
person, relating the possibility of dementia to herself and therefore tentatively integrating it 
into a personal discourse, caused her speech to become disjointed. She paused and repeated 
herself several times throughout her answer, possibly due to an emerging realisation of 
where a dementia discourse would position her. As Margaret showed, participants were 
explicit about dementia being a worry, with its previously mentioned negative connotations, 
and therefore there was anxiety and a reluctance to consider the related positioning as a 
person with dementia. The positioning of MCI in relation to dementia was similarly 
considered and explained by William. 
 
William: (When asked how he felt about being diagnosed with MCI) Actually it was a 
relief. [Okay] Because I thought it might’ve been something worse.  
Interviewer: Like?  
William: Alzheimer’s or something like that. [Right] But when I was told it was mild 
cognitive impairment, that, that was a relief. [Okay] Because it’s not that, well I 
believe it’s not that serious. [Yeah] So that re, that was, I didn’t think I was going, I 
found out I wasn’t going mental. [Okay] That helped a lot! 
 
William started with “actually”, suggesting that the opinion he was about to give was a 
potentially unexpected answer to the interviewer. When asked what he meant by “it”, his 
answer moved from a specific and emphasised “Alzheimer’s”, to vague, “or something like 
that”. However, his speech was then punctuated with repetition and not finishing the 
sentences, similar to Margaret above. To William, being diagnosed with Alzheimer’s was 
viewed as “going mental”, and in comparison, a diagnosis of MCI was a “relief”, attempting 
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to normalise the diagnosis of MCI. However his use of “that” repeatedly said with 
emphasis, suggested that MCI was to a certain degree also a “serious” matter. 
 
Although dementia, like ageing and dying, was a familiar and well-formed discourse for the 
participants, it only offered undesirable and unwanted social positions. Participants seemed 
to have some awareness that MCI may convert to dementia, even though they appeared to 
not to have exact knowledge of a possible prognosis of MCI. In their discourses, participants 
constructed a negative image of this diagnosis, and through their use of language they 
actively tried to distance themselves from it. 
 
 
Discussion 
 
Interviews with people who had been diagnosed with MCI, revealed three discourses 
associated with MCI: ‘Not Knowing’, ‘Knowing’ and ‘Not Wanting to Know’. There 
appeared to be no coherent discourse available to people around MCI, in which they would 
have been able to position themselves. This left participants searching for the experts who 
could explain and give them the language. In the absence of reliable experts, participants 
appeared to look for other discourses that were more familiar to them and that would help 
them to position themselves as being diagnosed with MCI, two discourses emerged: ageing 
and dying, and dementia. 
 
The findings of this study have built upon and added to the previously reported narrative 
accounts of those with MCI. Up until this point, the narrative accounts of those with MCI 
have primarily focused on exploring the experience of being diagnosed with and living with 
MCI. Studies have looked at the ways in which people try to make sense of the diagnosis, 
the coping strategies employed, and how people attribute symptoms (Beard & Neary, 2013; 
Berg et al., 2012; Corner & Bond, 2006; Joosten-Weyn Banningh et al., 2008; Lingler et al., 
2006; McIlavane et al., 2008; Roberts & Clare, 2013). Within this study, participants 
oscillated between wider available and generated discourses around ageing/dying and 
dementia, ‘Knowing’ and ‘Not Wanting to Know’. This tension in discourses between 
ageing and dying versus dementia was evident throughout the participants’ interviews, with 
participants borrowing from these more familiar discourses as a way of helping to find a 
position regarding their MCI diagnosis. Whilst previous studies have highlighted that people 
with MCI are likely to attribute memory loss to causes such as ageing or dementia (Beard & 
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Fox, 2008; Dean & Wilcox, 2012; Lingler et al., 2006), this study revealed that although 
ageing was seen as ambivalent and death as inevitable, participants attempted to position 
themselves within this discourse, rather than that of dementia, which only offered a dreaded 
position. Their use of language showed attempts at distancing themselves from the dementia 
discourse. However participants seemed aware of the possibility of dementia, despite not 
fully being informed of the prognosis of MCI.  
 
In western culture, people have access to different discourses to talk about old age, which 
can be both contrasting and conflicting (Jolanki, Jylhä, & Hervonen, 2000). On the one 
hand, old age is constructed as an external, inevitable fact. It is no one’s fault that old age 
means decline. This allows people to offer an explanation for why they are no longer as 
active as they used to be, have failing memories, become more reliant on others, allowed to 
receive help, and why they have permission to be ill or frail (Giles & Coupland 1991). 
However, receipt of these social privileges does contain some social risks, such as being 
viewed as helpless and dependant, or losing authority (Jolanki et al., 2000). An alternative 
discourse therefore, which preserves authority and allows someone to be treated as 
“accountable” (Shotter, 1993) is that of being independent and self-reliant. However, in 
order to do this, people must distance themselves from “the other old”, the sick and the frail, 
or else credibility is lost (Jolanki et al., 2000). Given the dilemmatic discourse of ageing, the 
participants within this study positioned themselves ambivalently within this discourse. 
They spoke of decline as expected (“common thing”, “[j]ust that you’re getting old”), which 
enabled MCI to be tentatively integrated into an ageing discourse. This gave them 
permission to acceptably reduce their activities, accept help, and become ill or frail. 
However, by utilising this discourse, people with MCI risked losing authority and being 
viewed as helpless or dependant, which a few of the participants then attempted to fight 
against (“I’m not a bloody idiot!”) in an attempt to create an alternative discourse. 
 
Terms and phrases used to describe people with dementia such as “there’s nobody there”, 
contribute to what has been termed a ‘social death’ (Sweeting & Gilhooly, 1997), which has 
become a pervasive view, reflected in novels, films and media reports of people with 
dementia. The negative connotations and fear associated with dementia, appeared to cause 
the participants to distance the MCI discourse from that of dementia. As social identities are 
also constructed by discourses, participants appeared to develop strategies to make the 
unmanageable manageable (Birenbaum 1992) by referring back to the known but 
ambivalent discourse of ageing and dying. If all stages of dementia are given the same 
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discourse (that of the end stages), then people diagnosed with MCI must attempt to 
differentiate their current position from that available in a dementia discourse in order to 
avoid being attributed the accompanying spoiled identity (Beard & Neary, 2013; Goffman, 
1963). Stigma is deeply social, and for those given aversive labels, these become social 
problems to be managed. Diagnostic labels and their associated discourses influence and 
create social identities through which social problems can be managed. A discourse which 
talks about a diagnosis of MCI as a ‘pre-dementia’ diagnosis could therefore create tensions.  
 
This study does have limitations. Firstly, the participants were drawn from a number of 
memory clinics across North Wales, which all operate differently in terms of the sharing of 
the diagnosis and pre and post diagnostic counselling. Therefore it is likely that participants 
were given different information and support. Indeed, one participant in this study knew 
they had been given written information although they had chosen not to read this due to 
fear that it would confirm that MCI was likely to convert to dementia in the future. 
Secondly, the participants who responded to take part in this study generally had higher 
levels of education than the general population, which may reflect a sample of potential 
participants more likely to respond to an invite to take part in research. This may have had 
an impact on their choice of language, and therefore the discourses that arose from their 
interviews. In addition all participants were first language English, with only one participant 
speaking Welsh as a second language. Thirdly, primarily only the participant’s speech was 
analysed for discourse, rather than analysing the interaction between both the participant and 
interviewer. Although the interviewer attempted to remain impartial, neutral and not 
influence the construction of discourse around the diagnosis of MCI, it is acknowledged that 
this may not have always been possible due to the very nature of interviews. Finally, it is not 
clear how or whether both verbal and non-verbal features in the interviews may have been 
related to or were a reflection of the cognitive impairment, rather than as a way of 
positioning themselves within the discourses. There are few studies that have used discourse 
analysis to study the language of people who have cognitive difficulties. The sample of 
participants were heterogeneous in their level of impairment, with some participants more 
recently diagnosed with fewer cognitive changes, and other participants reporting functional 
difficulties, which could be a symptom of a deteriorating condition like dementia. However, 
despite differing levels of cognitive impairment, the content of participants’ interviews was 
noticeably more fluent when they spoke about known discourses (ageing/dying and 
dementia) than MCI, suggesting that hesitant and disjointed speech was a feature of the 
discourse rather than that of cognitive impairment.  
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People with dementia are often regarded as unable to contribute to the social discourse of 
their condition, or even narrate their own experience of illness (Beard & Neary, 2013).  
Similarly, people with MCI seem likely to become the victim of this discourse, where 
people with cognitive impairment cannot contribute to the discourse of the diagnosis they 
have been given. People with MCI must be given the opportunity to contribute to the social 
discourse of their diagnosis, and share their experience and knowledge. This study showed 
that the MCI discourse is not well established outside a research and clinical context, and 
can only be understood by those diagnosed with MCI in the context of fear of dementia, or 
the ambivalence of ageing and dying. Whilst an ageing and dying discourse does not 
threaten the identity of people with MCI, the knowledge that MCI could deteriorate and lead 
to a dementia discourse does. With a dementia discourse as a potential future option, people 
with MCI will become fearful of their positioning in the future and could create unnecessary 
complications and possible compliance with dominant discourses. 
 
With this in mind, clinicians must consider both the amount of and how information is 
presented to patients about MCI at pre and post diagnostic counselling, including where 
MCI is positioned in respect to dementia. Pre and post diagnostic counselling are primary 
opportunities for the clinician to help people with MCI shape the discourse around the 
diagnosis, which may help them to meaningfully integrate the diagnosis into a supportive 
discourse, rather than become susceptible to other discourses which each pose challenges. 
However, this poses a further question – do clinicians have a well-formed discourse around 
MCI? No studies so far have specifically looked at memory clinic clinician’s views of the 
diagnosis, or the language that they use to speak about MCI and make sense of it for 
patients. Alternatively, the current lack of discourse around MCI may provide an 
opportunity for those most intimately affected by it, to contribute to it and shape it.  
 
Over time it would appear that clinical research and medical experts have imposed the 
diagnosis of MCI on the general public, and into current medical discourse. The findings of 
this study would suggest that currently there is a lack of discourse around MCI and this 
provides people with the opportunity to influence the discourse around MCI and decide 
whether it is a meaningful or helpful social construction and label.  
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The overlapping themes of the two papers were that of watchful waiting and uncertainty. 
Clearly prostate cancer and mild cognitive impairment are very different diagnoses, viewed 
as sitting in two very different categories, one within the physical health and the other in the 
mental health domain (although one might argue MCI is a neurological condition and 
therefore also physical). However there are also some distinct similarities and therefore 
opportunities for each area to learn from the other.  
 
Watchful waiting in prostate cancer is a defined treatment option that men with prostate 
cancer can actively choose as a way of monitoring their disease progression. In mild 
cognitive impairment, there is very little choice regarding treatment options, and people are 
invited to attend (often annual) reassessments to assess progression.  However, the essence 
of watchful waiting in both conditions are quite similar – in both instances disease 
progression is monitored at regular intervals, with no treatment given or available until the 
disease progresses (prostate cancer becomes clinically symptomatic or MCI converts to 
dementia), and even then the treatment is not curative (men with prostate cancer given 
palliative treatments and people with dementia given medication in an attempt to slow 
progression).  
 
The primary difference between the watchful waiting in the two conditions considered in the 
two papers, is that for men with prostate cancer in watchful waiting this is a choice, while 
for people with mild cognitive impairment, the watchful waiting is not out of choice, at the 
moment there appears to be no real clinical alternative. It is therefore possible that the 
element of choice for men with prostate cancer undertaking watchful waiting in some ways 
changes and influences the type of uncertainty felt around treatment, in comparison to the 
uncertainty felt by people with MCI, where there is no choice regarding treatment. The 
impact of choice on how a person manages a diagnosis of uncertainty and the impact of this 
on their wellbeing creates worthwhile considerations for both future research and health care 
providers.  
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The implications for prostate cancer and MCI theory development, future research and 
clinical implications will be considered in turn, and links drawn between the two fields. 
 
Implications for theory development 
Prostate cancer 
 
Although, the research appears to still be in its infancy for both watchful waiting in prostate 
cancer and MCI, prostate cancer research is a few steps ahead in specifically exploring 
uncertainty, how it may impact on people’s wellbeing, and how this knowledge can be 
applied to help men adjust to an uncertain future. Mishel’s (1988) ‘uncertainty in illness 
model’ has been used as a framework to understand uncertainty in watchful waiting. 
Uncertainty has been defined as a "cognitive state created when the person cannot 
adequately structure or categorize an event due to a lack of sufficient cues and thereby 
cannot determine the meaning of the illness-related events" (Mishel & Epstein, 1997).  
 
Mishel (1988) viewed uncertainty as the greatest psychological stressor for people coping 
with life threatening illnesses, such as prostate cancer. In these situations, individuals, either 
directly or indirectly affected by the condition, cannot accurately predict disease outcomes 
(e.g. severity of illness, symptoms, impact on future). The ‘uncertainty in illness model’ 
proposes that uncertainty develops from several life factors and is mediated by personality 
characteristics and the personal style in which uncertainty is understood (Mishel, 1988). 
When diagnosed with a life threatening illness, uncertainty around disease and symptom 
progression can extend to uncertainty around wider life issues and ability to achieve life 
goals. This extension occurs as a result of uncertainty affecting normal routines, which 
eventually may lead to a disruption of the person’s sense of structure and order. However, 
uncertainty may then be used by people to reorganise and recreate their life view, suggesting 
uncertainty can function as a catalyst for people to move from a life view with set choices to 
a life view with enhanced flexibility and multiple opportunities (Mishel, 1988).  
 
Research into watchful waiting in prostate cancer has found that, based on Mishel’s (1988) 
model, men who initially seemed to experience an increased sense of uncertainty and danger 
perception reported poorer quality of life (Wallace, 2003). However, over time their 
perceived quality of life was not significantly different from people undergoing a range of 
medical treatments. Uncertainty is also a key theme that has appeared in qualitative 
interviews with men who chose watchful waiting as their treatment for prostate cancer 
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(Bailey, Wallace & Mishel, 2007; Hedestig, Sandman & Widmark, 2003). The only psycho-
interventional study with men undertaking watchful waiting (Bailey, Mishel, Belyea, 
Stewart & Mohler, 2004), was based on Mishel’s (1988) model, and found that after the 
intervention, men reported an increase in quality of life and ultimately came to see their 
lives in a new light. This highlights how uncertainty can prove to be a catalyst for change. 
 
The ‘uncertainty in illness model’ has begun to be used as a theoretical framework for 
understanding the appraisals made by men with prostate cancer in watchful waiting. 
However, there continues to be a lack of evidence within this area, which has not 
significantly progressed since the intervention study in 2004 (Bailey et al., 2004). In order to 
strengthen the theory, more high quality research needs to be conducted, with larger samples 
of men and where possible in other conditions where watchful waiting might be a suitable 
treatment option.  
 
Mild Cognitive Impairment 
 
Whilst MCI in itself is not a life threatening diagnosis, for patients it holds an uncertain 
future in terms of how it might develop into a possible dementia, stay the same or 
functioning reverts back to similar levels to before being diagnosed with MCI. It has been 
suggested that a MCI diagnosis may also escalate people’s uncertainty, compelling them to 
re-evaluate their psychosocial situation (Joosten‐Weyn Banningh, Vernooij‐Dassen, Rikkert 
& Teunisse, 2008). Dementia can be viewed as a metaphorical threat to life, and as such 
people’s lives have the potential to dramatically change if the MCI progresses into dementia 
(Zeilig, 2014). Often people diagnosed with MCI will be cognitively reassessed every six 
months to a year, watching and waiting for change. This watchful waiting is has similarities 
with the experience of those waiting with physical illnesses, like prostate cancer.  
 
Given the similarities between the experiences of uncertainty between men with prostate 
cancer undertaking watchful waiting and people diagnosed with MCI, future theory 
development in the MCI field could consider the benefit of using Mishel’s (1988) 
‘uncertainty in illness model’ as a theoretical framework to understand people’s experience 
of a diagnosis of MCI. Psychological and social factors influence the accurate appraisal of 
cognitive difficulties in people with MCI (Roberts & Clare, 2013), and therefore a more 
coherent understanding of the many factors that influence their appraisals and understanding 
of the MCI diagnosis is essential. Greater theoretical understanding of these factors would 
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be with the ultimate aim of being able to provide appropriate clinical support and 
interventions.  
 
Implications for future research 
Prostate cancer 
 
Taking a close look at watchful waiting as a treatment option for prostate cancer exposed 
confusing medical discourses. The term ‘watchful waiting’ was often used interchangeably 
with a number of other terms such as active surveillance, expectant management and 
observation. Historically these terms were used without specific definitions (Ganz et al., 
2012), which has confused the scientific literature on observation (Ip et al., 2011). Watchful 
waiting and active surveillance are distinctly different treatment options. Watchful waiting is 
a conservative management strategy for men who are more likely to die from co-
morbidities, and when symptoms progress palliative treatment options remain available 
(Parker, 2003; Klotz, 2005). In comparison active surveillance delays curative treatment 
until it is necessary based on disease progression (Weissbach & Altwein, 2009). Although 
both delay treatment, when the prostate cancer becomes symptomatic, the treatment options 
are distinctly different with different functions. This means that it is likely that the two 
treatment options will have different psychological outcomes, regarding factors like 
uncertainty. Using these terms interchangeably, with no specific definition means that the 
subtle differences between these two treatment options may get lost, not only in the 
discourses of the medical research and clinical practice, but also for patients.  
 
The review conducted also revealed a wide variety of measures and questionnaires used, 
with variability in what components of the measures were reported. Fourteen different 
measures and questionnaires were included and reported in this review, which meant that it 
was difficult for the data to be brought together and direct comparisons made. Indeed one of 
these measures was a study specific questionnaire that had been validated in an unpublished 
study and was used by the only randomised control trial reported within the review. Two 
questionnaires were used more consistently within the studies, however the data reported in 
the studies was variable, again meaning direct comparisons were difficult to draw. Future 
research into the psychological aspects of watchful waiting must use specific, validated 
measures more consistently, in order for direct comparisons to be drawn. Furthermore, 
measures used in future research could assist with understanding the possible theoretical 
concepts that may be underpinning the anticipated findings.  
Contributions to Theory, Research and Clinical Practice 
92 
 
 
As a result of the variety of study designs, a mixed methods review had to be undertaken. 
The mixed method review is emerging as a new form of literature review, providing rich and 
detailed understanding of specific research areas (Pluye, Gagnon, Griffiths & Johnson-
Lafleur, 2009). However, there is a distinct lack of quality assessment tools for mixed 
methods reviews that include both quantitative and qualitative studies. Only one tool was 
found by the first author (Pluye, 2011). Although this tool brought together a variety of 
research methodologies, only four questions were asked of each study for the different 
designs (Appendix). This meant that a limited number of quality criteria were considered, 
and only a limited range of overall scores given, therefore potentially not making a clear 
distinction between the quality of the studies. If mixed methods reviews are to be treated 
with the same standard as used in a systematic review or meta-analysis, the lack of quality 
assessment tools must be addressed. 
 
Mild Cognitive Impairment 
 
Whilst completing clinical interviews was familiar to the first author as a trainee clinical 
psychologist, completing research interviews as a ‘researcher’ provided a number of 
challenges. Firstly, as discourse analysis relies on naturalistic speech, this meant the first 
author had to be careful not to influence the language used by the participant. It required 
awareness and monitoring to ensure that no leading questions were asked that would 
influence the participant’s language. Secondly, the research method, discourse analysis, 
meant learning to look and understand the interviews in a different light. Instead of studying 
the lived experiences of those with MCI, which fits more comfortably within the realms of 
clinical psychology, discourse analysis falls under a social constructionist approach. In 
discourse analysis, language is not seen as a transparent tool in the depiction of reality, 
instead it is proposed that people use language to build different versions of the social world 
(Potter & Wetherell, 1987). This alternative viewpoint highlighted how careful researchers 
need to be with language and terminology used during interviews with participants, as they 
themselves may influence the participants’ discourse. Additionally, clinicians may 
inadvertently affect the discourse during clinical interviews and this part of the constructed 
world of the person. 
 
MCI, a research defined concept (Peterson & Morris, 2005), is now considered a diagnosis, 
and would therefore benefit from a clearer idea of the conversion rate from MCI to 
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dementia. Conversion rates are reported to vary from 2% to 31% (Bruscoli & Lovestone, 
2004), suggesting a huge uncertainty around whether or not people convert to dementia, stay 
the same or even revert to normal. Whilst the prognosis of MCI remains so uncertain, people 
with MCI clearly struggle to make sense of the diagnosis. Therefore questions around the 
helpfulness of the diagnosis must be asked by clinicians giving the diagnoses. Drawing on 
the discourses of people with MCI – is MCI medicalising normal ageing? This becomes 
particularly relevant when the scientific basis of the organic nature of dementia is considered 
confused and unclear in itself (Bender, 2014).  
 
During analysis of the interviews by the first author, it became apparent that alternative 
qualitative research methods could also be used to analyse the data and produce meaningful 
results. Interpretative phenomenological analysis and grounded theory approaches had 
already been reported in the literature; however a more specific version of discourse 
analysis, Foucauldian discourse analysis, would have shed a different light on the data. 
Foucauldian discourse analysis is again concerned with language and how language is used, 
however it goes on to look at the discursive resources available to people, and the ways in 
which discourse reflects subjectivity and power relationships (Willig, 2013). A medical 
diagnosis is seen as a reflection of knowledge by an expert, who through this exerts power 
over the patient, who is manoeuvred into a position of subjectification (Willig, 2013). 
Throughout ongoing surveillance via regularly repeated reviews and reassessment, further 
power and control is exerted, and patients begin to monitor their own abilities. This concept 
was touched upon by participants in the study: 
 
Gwen: But I’ve seen myself get up at 2 o’clock in the morning and write a note… 
Margaret: It’s reassuring to know that somebody’s keeping an eye on you. 
 
While Gwen refers to self-monitoring, Margaret touches on the concept of surveillance; 
where others monitor her. By creating the MCI diagnostic label, it has socially constructed 
the perception of a need for increased surveillance of the self, which might reflect the 
influence and power exerted over current and future generations of older people (Beard & 
Neary, 2013). 
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Implications for clinical practice 
Prostate cancer 
 
The review highlighted that, for men choosing watchful waiting as a treatment option for 
prostate cancer, there was a period of initial uncertainty which caused a number of 
psychological symptoms, such as anxiety and depression, which impacted on their quality of 
life. This finding would suggest that the opportunity to access psychological support during 
this period would be highly beneficial for these men, whilst initially being informed of the 
possible psychological consequences of this choice. Recent National Institute for Health and 
Care Excellence (NIHCE) guidelines (2014) mentioned the benefit of psychological support 
for all men diagnosed with prostate cancer, however this document does not state how this 
support should be set out or indeed who is best placed to do it. Clinical psychology could 
either provide this service or otherwise is ideally placed in providing consultation and 
supervision to staff providing the support to the men. 
 
The NIHCE guidelines (2014) define watchful waiting as a viable treatment option for men 
in the United Kingdom. Indeed, the guidelines point out that if only patient survival is taken 
into account, then the curative treatment of radical prostatectomy is most cost effective. 
However, when quality of life was considered by the guidelines, with respect to both the 
underlying prostate cancer and side effects of treatment, watchful waiting then becomes the 
more desirable option, both in terms of expected costs and quality adjusted survival.  
 
However, the studies included in this review were often unclear on the choice the men had 
made in their treatment option, particularly the choice of watchful waiting. Watchful waiting 
as a choice option was implied rather than explicit in many of the studies. In contrast, two 
studies were part of a large randomised control trial, which meant the men did not have a 
choice in this treatment option. As noted in the review, one study (Katz & Rodriquez, 2007) 
reported offering watchful waiting as a viable treatment option, on par with curative 
treatments, and possibly as a result of this found that the choice of watchful waiting for these 
men did not impact on quality of life. Therefore, the way that watchful waiting is presented 
to men with prostate cancer as a treatment option may affect psychological outcomes. If it is 
presented as a second class option, then men are potentially at increased risk to experience 
uncertainty around the treatment decision. Careful pre and post diagnostic counselling is 
therefore required, with additional attention to the psychological impact of the options 
available. 
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Mild Cognitive Impairment 
 
The use of the term MCI also has implications for clinical practice. MCI was originally 
created for research purposes in order to identify a group of people at risk of developing 
dementia, and the criteria for MCI has been refined over time (Peterson & Morris, 2005). 
The diagnosis is now included in DSM-5 (American Psychiatric Association, 2013), under 
the category of Neurocognitive Disorders, and given the label of ‘mild neurocognitive 
disorder’. This diagnosis does identify a group of people some of whom potentially are in a 
pre-dementia phase and who could be researched. However, in the absence of a clear 
aetiology, prognosis or recommended treatments as yet identified (Peterson, 2011) the 
clinical usefulness of this diagnosis is questionable. Furthermore, there is no evidence to 
suggest that early diagnosis affects rates of progression or prevents crises (Brunet, 2013). 
Early diagnosis may instead force people onto a trajectory of disability (Bender, 2014). 
Instead, the qualitative research into MCI suggests that people try to make sense of the 
diagnosis within the context of fear and uncertainty, and that people do not know where to 
position themselves in terms of normal ageing or dementia.  
 
The information that people with MCI are given at diagnosis varies. The one participant in 
this study who reported being given information, had received a leaflet from the 
Alzheimer’s Society. He reflected that although he thought that the Alzheimer’s Society was 
probably best placed to give the information, he was so concerned that the information 
would explicitly state that MCI would ultimately lead to dementia, he decided not to read it. 
By giving people with MCI information created by the Alzheimer’s Society, even if of good 
quality, it immediately strengths the positioning of MCI as close to dementia. People are 
likely to just see ‘Alzheimer’s disease’ and not necessarily appreciate the uncertainty of the 
association (Peterson, 2011). During post-diagnostic counselling, people with MCI may not 
be able to take in all the information given, due to cognitive problems and anxiety. Indeed 
many of the participants in this study were unable to clearly recall when and what they were 
told about the diagnosis of MCI. 
 
Whilst clinicians are best placed to give people diagnosed with MCI correct information and 
support, given the uncertainty of the diagnosis, they may be unable to do so in a coherent 
manner. This in turn may impact on the discourse people with MCI hold around the 
diagnosis. Staff themselves may not only lack knowledge around MCI and the possible 
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trajectories, they might also be reluctant to have open and frank discussions regarding the 
diagnosis and its meaning with patients. Staff may not have the answers to the patients and 
families questions, and therefore would not be viewed as an expert. This resonates with the 
Foucauldian discourse analysis concepts of knowledge and expert power. 
 
Even following diagnosis of MCI, there are limited services available to people diagnosed 
with this condition, further influencing a discourse and the experience of uncertainty. After 
diagnosis, the only contact they are likely to have, regarding the diagnosis of MCI, is with 
mental health services for reassessment, which is likely to be approximately one year after 
initial assessment and diagnosis. Very little psychoeducational or interventional support is 
available in the meantime. People are in effect, given a diagnosis which they both struggle to 
make sense of and incorporate into their identity, as there is no clear discourse around it, and 
left without contact with services unless their reported difficulties become significantly 
worse.  
 
It could be argued that services have both a moral and ethical responsibility to support the 
people who have been given a diagnosis appropriately. A robust theoretical framework into 
the experiences of people diagnosed with MCI, as previously discussed in ‘theoretical 
implications’, may inform appropriate therapeutic interventions for this group of people, to 
help manage uncertainty and the psychological impact of the diagnosis. The aim of a more 
robust theoretical framework to understand the experiences of those with MCI would 
ultimately be to design an intervention aimed at helping people adjust and adapt to the 
uncertainty of the diagnosis, and potentially improve quality of life. With this in mind, 
relevant adaptations need to be made so that interventions are accessible to people whose 
cognitive abilities can be affected, in terms of pace, processing speed, comprehension, recall 
and execution. Furthermore, a clearer understanding of the conversion rates, and factors 
contributing to this, might also lead to biopsychosocial interventions that might be able to 
maintain current levels of competencies or even reverse them.  
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The amendment is fine - the only (tiny) comment I have is that I would 
suggest removing the comma after someone and before regarding in the 
"sources of support" document. 
Approval 
Status: 
Approve without amendment 
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Research Ethics Committee Details of amendments 
 
Miss Sian Pierce  
Trainee Clinical Psychologist  
North Wales Clinical Psychology Programme 
   School of Psychology  
Bangor University  
43 College Road Bangor 
 Gwynedd  
LL57 2DG   
5th August 2014 
 
Dear Mr Derek Crawford, 
 
REC reference: 14/WA/1072 
 
I am writing to inform you that I have made the changes agreed in the Research Ethics 
Committee meeting on the 17th July 2014. 
 
In relation to the changes made to the Participant Information Sheet, I have: 
 
a) Removed the Bangor University logo from the word document, and will print off the 
documents on Bangor University headed paper. 
b) Written consistently in the first person. 
c) Briefly explained the meaning of the use of the word ‘discourse’, under the heading 
‘Purpose of the Study’. 
d) Rephrased “this study will help us to understand the diagnosis and what it means to 
people” under the heading of ‘Purpose of the Study’, to “By understanding the 
language people use to talk about a diagnosis of Mild Cognitive Impairment, it is 
hoped that this will help clinicians who use the diagnosis to understand what it means 
to people.” 
e) Clarified that talking through the interview process and gaining consent may take 15 
to 20 minutes, followed by an interview of no longer than one hour. 
 
In relation to the changes to the Consent form, I have added a tick box for the participants to 
agree to their GP being informed that they have taken part in the study. This information has 
also been updated on the Participant Information Sheet. 
 
Further to our discussion around how long Bangor University will keep the data after the 
study has been completed, I have been informed that this is 5 years.  The Participant 
Information Sheet has been updated to include this. 
 
I enclose the updated versions of the Participant Information Sheet and Consent Form, with 
the changes highlighted. 
 
If you would like any further information then please contact me. 
 
Yours sincerely,  
 
Sian Pierce
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Research and Development Details of amendments 
 
Miss Sian Pierce  
Trainee Clinical Psychologist  
North Wales Clinical Psychology Programme 
   School of Psychology  
Bangor University  
43 College Road Bangor 
 Gwynedd  
LL57 2DG   
5th September 2014 
 
Dear Dr Nefyn Williams, 
 
IRAS Reference:  140596 
 
I am writing to inform you that I am able to provide additional information and resolve the 
issues identified in the Research and Development Internal Review Panel in its meeting on 
the 14th August 2014. 
 
Implications for internal departments assessed  
The study has been discussed with Dr Giles Harborne, Chief of Staff.  I have attached the 
relevant form with Dr Giles Harborne’s signature to confirm that he is in agreement with the 
study. 
 
Compliance with Data protection and data security issues assessed  
The data will be stored on an encrypted memory stick, and not saved on the researcher’s 
personal laptop or on the recording device. 
 
The data will be stored for a period of 5 years by Dr Katie Salisbury, who is a Research 
Supervisor on this project. She will ensure that the data is destroyed after the period of 5 
years. Data will be stored in a locked cabinet in her office at Flintshire Mental Health 
Services for Older People, Wepre House, Wepre Drive, Civic Centre, Connah’s Quay, CH5 
4HA. 
  
If you would like any further information then please contact me. 
 
Yours sincerely,  
 
Sian Pierce 
 
Research and Development Approval granted 
187 
 
Research and Development Approval granted 
 
Ethics Appendix 
188 
 
  
Ethics Appendix 
189 
 
 
General Appendix 
190 
 
General Appendix 
 
Appendix 1.1  
191 
 
Appendix 1.1: Mixed Methods Appraisal Tool Quality Rating 
 
Table 1: Mixed Methods Appraisal Tool Quality Rating 
Study designs Methodological quality criteria 
1. Qualitative 1.1. Are the sources of qualitative data (archives, documents, informants, 
observations) relevant to address the research question (objective)?  
1.2. Is the process for analysing qualitative data relevant to address the 
research question (objective)?  
1.3. Is appropriate consideration given to how ﬁndings relate to the 
context, e.g., the setting, in which the data were collected?  
1.4. Is appropriate consideration given to how ﬁndings relate to 
researchers’ inﬂuence, e.g., through their interactions with participants? 
2. Quantitative 
randomised 
control (trial) 
2.1. Is there a clear description of the randomization (or an appropriate 
sequence generation)?  
2.2. Is there a clear description of the allocation concealment (or blinding 
when applicable)?  
2.3. Are there complete outcome data (80% or above)? 
2.4. Is there low withdrawal/dropout (below 20%)? 
3. Quantitative 
non-
randomised 
3.1. Are participants (organizations) recruited in a way that minimizes 
selection bias?  
3.2. Are measurements appropriate (clear origin, or validity known, or 
standard instrument; and absence of contamination between groups when 
appropriate) regarding the exposure/intervention and outcomes?  
3.3. In the groups being compared (exposed vs. non-exposed; with 
intervention vs. without; cases vs. controls), are the participants 
comparable, or do researchers take into account (control for) the 
difference between these groups?  
3.4. Are there complete outcome data (80% or above), and, when 
applicable, an acceptable response rate (60% or above), or an acceptable 
follow-up rate for cohort studies (depending on the duration of follow-
up)? 
4. Quantitative 
descriptive 
4.1. Is the sampling strategy relevant to address the quantitative research 
question (quantitative aspect of the mixed methods question)? 
4.2. Is the sample representative of the population understudy?  
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4.3. Are measurements appropriate (clear origin, or validity known, or 
standard instrument)?  
4.4. Is there an acceptable response rate (60% or above)? 
5. Mixed 
methods * 
 
*Not included as there were no mixed methods studies included in this review. 
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Appendix 2.1: Demographic Information 
 
Demographic Questions 
 
 
Participant Number: 
 
 
Gender: 
 
Age: 
 
Ethnicity: 
 
Married: 
 
Education: 
 
 
Informed consent gained: 
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Appendix 2.2: Information Sheet for Memory Clinic Clinicians 
4/7/2014 Version 1 
 
RHAGLEN SEICOLEG CLINIGOL GOGLEDD CYMRU 
NORTH WALES CLINICAL PSYCHOLOGY PROGRAMME 
 
Information Sheet for Memory Clinic Clinicians 
 
Study Title: How do people with a diagnosis of Mild Cognitive Impairment use discourses to 
interpret the diagnosis?  
 
Research Team: Sian Pierce (Trainee Clinical Psychologist), Dr Katie Salisbury (Older 
Adults Clinical Psychologist), and Dr Carolien Lamers (Older Adults Clinical Psychologist). 
North Wales Clinical Psychology Programme, Bangor University. 
 
You are invited to assist in the recruitment for this study. This information sheet contains 
information about the study, but please contact me if you have any further questions. 
 
This study will be looking at how people with a diagnosis of Mild Cognitive Impairment 
(MCI) talk about this condition and how they understand it. It is hoped that the findings will 
further help clinicians understand the impact of this diagnosis, and what it means to people 
and their position in society to have MCI. This study is being completed as part of a thesis at 
the North Wales Clinical Psychology Programme, Bangor University, by Sian Pierce 
(Trainee Clinical Psychologist) and has been reviewed and approved by the ethics committee 
of the School of Psychology, Bangor University, and NHS Research and Development, Betsi 
Cadwaladr University Health Board. 
 
The study will involve an interview which will be recorded, of no longer than one hour, 
which will be completed by Sian Pierce (Trainee Clinical Psychologist). The interview will 
take place at the participant’s home or at a local NHS facility. 
 
In order to protect confidentiality, potential participants will be identified by yourselves, as 
staff who are working with people with MCI and who know the person who may be 
interested in taking part. 
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The study has a few inclusion and exclusion criteria for potential participants. 
 
Inclusion criteria: 
A diagnosis of MCI which has been confirmed by the Memory Clinic 
multi-disciplinary team,   
The ability to fluently communicate verbally in English, 
The ability to give informed consent to take part in the study,   
Aged 55 or over.   
 
Exclusion criteria: 
A co-morbid diagnosis (including a mental health diagnosis or physical health diagnosis), 
Language difficulties (such as aphasia). 
 
If you have identified someone who fits these criteria, and who you think may be interested 
in taking part in the study, could you please initially inform them (either face to face or 
telephone call) about the study and give them the included information pack, which contains 
further information about the study, including consent and confidentiality. There is a reply 
slip included in the information pack, with a stamped addressed envelope, for the potential 
participant to send back if they are willing to be contacted about the study. In order to protect 
confidentiality, I will not be able to contact the potential participants unless they return the 
reply slip with their contact details on to me. Of course there is no obligation for the person to 
take part in the study.  
 
If someone you have identified agrees to take part in the study, the usual limits of 
confidentiality apply. You will only be contacted if I am concerned that the participant is at 
risk of harm from themselves or others. Their GP will not know they have taken part in the 
study.  
 
If you have any further questions or would like further information please contact: 
 
Sian Pierce 
North Wales Clinical Psychology Programme, 
Department of Psychology, 
43 College Road, 
Bangor, 
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Gwynedd, 
LL57 2DG 
psp0d8@bangor.ac.uk 
01978 726932 (please leave a message and I will get back to you) 
 
 
If you have any complaints about how this study is conducted, please address these too: 
 
For an NHS complaint:  Concerns Team  
Betsi Cadwaladr University Health Board   
Ysbyty Gwynedd  
Bangor  
Gwynedd 
LL57 2PW 
Email: ConcernsTeam.bcu@wales.nhs.uk 
Tel: 01248 384194 
 
For a University complaint:  Hefin Francis (School Manager) 
School of Psychology 
Adeilad Brigantia 
Penrallt Road 
Gwynedd LL57 2AS 
Email: h.francis@bangor.ac.uk 
Tel: 01248 388339 
 
 
Thank you very much for taking the time to read this information and assisting in the 
recruitment of this study. 
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Appendix 2.3: Information Pack for Potential Participants 
1/8/14 Version 2 
 
RHAGLEN SEICOLEG CLINIGOL GOGLEDD CYMRU 
NORTH WALES CLINICAL PSYCHOLOGY PROGRAMME 
 
Information Sheet 
 
Study Title: How do people with a diagnosis of Mild Cognitive Impairment use discourses to 
interpret the diagnosis?  
 
Research Team: Sian Pierce (Trainee Clinical Psychologist), Dr Katie Salisbury (Older 
Adults Clinical Psychologist), and Dr Carolien Lamers (Older Adults Clinical Psychologist). 
North Wales Clinical Psychology Programme, Bangor University. 
 
Invitation to Participation 
You are invited to read this information sheet to help you decide whether you would like to 
take part in this study. Please contact me (Sian Pierce) if you would like any further 
information, and take your time to make your decision. My contact details are at the end of 
this information sheet. 
 
Purpose of the Study 
The study will be looking at how people with a diagnosis of Mild Cognitive Impairment talk 
about it and understand it. This study will look at the use of ‘discourses’, which is the 
language that people use to talk about a particular topic. By understanding the language 
people use to talk about a diagnosis of Mild Cognitive Impairment, it is hoped that this will 
help clinicians who use the diagnosis to understand what it means to people. This study is 
being completed as part of a thesis at Bangor University. 
 
What will the study involve?  
The study will involve a recorded interview with me (Sian Pierce). Initially I will talk you 
through the interview process and then ask you to sign the consent form, which may take 15 
to 20 minutes. The interview itself will take no longer than one hour. The interview can take 
place at your home or at a NHS facility near you. If you travel to take part in the study, your 
travel expenses will be reimbursed. 
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Why have you been invited to take part?  
You have been invited because you have been given a diagnosis of Mild Cognitive 
Impairment by the Memory Clinic.  
 
Do you have to take part?  
No, your participation is voluntary. A member of the memory clinic team, who knows you, 
has identified you as somebody who might be interested in taking part in this study.  The 
memory clinic team will not be able to give me your information, so if you are interested in 
taking part, please send the attached reply slip back, in the stamped addressed envelope. 
 
When we meet, I will explain the nature of the study to you and answer any further questions 
you may have. If you are happy to proceed, you will be asked to sign a consent form. 
However, you can withdraw from the study at any point and any information you have 
provided will be destroyed or removed. This means that you can withdraw part-way through 
or at the end of the interview. 
 
Will your participation in the study be kept confidential?  
Yes, only your GP will be informed that you have participated in the study. The usual limits 
of confidentiality will apply, in that I will only discuss your participation in the study with a 
member of the Memory Clinic if I am concerned that you or other people are at risk of harm. 
I will always discuss any concerns I may have with you before I speak to colleagues. 
 
The study will be written up as part of a doctoral thesis. However, all information will be 
anonymised and any clues as to your identity will be removed. Any quotes from you used in 
the thesis will be entirely anonymous. Disguised extracts from the interview may be quoted 
in the thesis and any subsequent publications. 
 
What will happen if you are interested in taking part in the study? 
If you are interested in taking part in the study, or have any further questions, please complete 
the reply slip included in this information pack and post it in the attached freepost envelope. 
When I have received the reply slip, I will contact you to arrange a time to meet. This might 
be at your house or at a NHS facility near you. 
 
When we meet we will further discuss consent, confidentiality and your right with withdraw 
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at any point. Should you wish to continue, you will be asked to complete a consent form and 
some demographic questions (such as age, and when you were initially diagnosed with Mild 
Cognitive Impairment). The interview will then take place and be recorded. 
 
What will happen to the information you give?  
The information you have provided and the interview itself, will be kept confidential for the 
duration of the study. On completion of the thesis, the information will be retained for a 
further five years and then destroyed and the recording removed. 
 
What will happen to the results?  
The results will be presented in the thesis. They will be seen by the research supervisors, a 
second marker and the external examiner. The thesis may be read by future students on the 
course. The study may be published in a research journal. 
 
If you are interested in the results of the study, I will send you a summary once the study has 
been completed. 
 
What are the possible disadvantages of taking part? 
I do not envisage any negative consequences for you in taking part, however it is possible 
that talking about your experience in this way may cause some distress. At the end of the 
interview, I will discuss with you how you found the experience and how you are feeling. I 
will give you an information sheet at the end of the interview with contact numbers for 
support, should you feel distressed, or you could contact your GP. You can also withdraw 
from the study at any point. 
 
Who has reviewed this study?  
This research has been reviewed and approved by the ethics committee of the School of 
Psychology, Bangor University, and the NHS Research and Development, Betsi Cadwaladr 
University Health Board. 
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If you would like any further information, please contact: 
 
Sian Pierce 
North Wales Clinical Psychology Programme 
Department of Psychology 
43 College Road 
Bangor 
Gwynedd 
LL57 2DG 
psp0d8@bangor.ac.uk 
01978 726932 (please leave a message and I will get back to you) 
 
If you have any complaints about how this study is conducted, please address these too: 
 
For an NHS complaint:  Concerns Team  
Betsi Cadwaladr University Health Board   
Ysbyty Gwynedd  
Bangor  
Gwynedd 
LL57 2PW 
Email: ConcernsTeam.bcu@wales.nhs.uk 
Tel: 01248 384194 
 
For a University complaint:  Hefin Francis (School Manager) 
School of Psychology 
Adeilad Brigantia 
Penrallt Road 
Gwynedd LL57 2AS 
Email: h.francis@bangor.ac.uk 
Tel: 01248 388339 
 
Thank you very much for taking the time to read this information and considering taking part 
in this study. 
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Reply Slip 
 
If you are interested in taking part in the research, please fill in this reply slip and post it in 
the envelope provided. You do not need to put a stamp on the envelope. 
 
 
I am interested in taking part in this research. I would like the researcher to contact 
me.  
 
 
 
My name: 
 
 
My telephone number: 
 
 
My email address: 
 
 
My address: 
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Appendix 2.4: Consent Form 
1/8/14 Version 2 
 
RHAGLEN SEICOLEG CLINIGOL GOGLEDD CYMRU 
NORTH WALES CLINICAL PSYCHOLOGY PROGRAMME 
 
CONSENT FORM 
Study Title: How do people with a diagnosis of Mild Cognitive Impairment use discourses to 
interpret the diagnosis?  
Research Team: Sian Pierce (Trainee Clinical Psychologist), Dr Katie Salisbury (Older 
Adults Clinical Psychologist), Dr Carolien Lamers (Older Adults Clinical Psychologist). 
Please initial all boxes  
1. I confirm that I have read and understand the information sheet for the above 
study.  I have had the opportunity to consider the information, ask questions 
and have had these answered satisfactorily. 
   
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason, without my medical care or legal 
rights being affected. 
 
3. I agree for my GP to be informed that I have taken part in this study. 
 
4. I give permission for my interview to be recorded. 
 
5. I understand that anonymity will be ensured in the write-up by disguising my 
identity. 
 
6. I understand that disguised extracts from my interview may be quoted in the 
thesis and any subsequent publications.  
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7. I would like to receive a summary of the findings of the study, when the 
study is completed. 
 
8. I agree to take part in the above study.    
 
 
            
Name of Participant   Date    Signature 
                                
            
Name of Chief Investigator  Date    Signature   
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Appendix 2.5: Interview Schedule 
4/7/2014 Version 1 
 
Interview Schedule 
 
When using discourse analysis, as much natural conversation as possible should be allowed, 
in order to elicit and identify discourses. Therefore a semi-structured interview will be used. 
 
Introduction 
I would like to talk to you about when you were told that you have Mild Cognitive 
Impairment.  
 
Externalizing 
It was decided that the interviewer should refrain from presenting the definitions, and let the 
participants create the reality.  
1. Can you say what you think Mild Cognitive Impairment is? 
a. Possible follow up if the participant mentions dementia: How is it the 
same/different? 
2. Had you heard about Mild Cognitive Impairment before? 
 
Personalizing 
1. How has being told you have Mild Cognitive Impairment influenced your life? 
2. How do you describe/think about yourself now, compared to before? 
3. What do your family and friends say about this? 
 
Specifying 
1. Can you say what the advantages are of knowing you have Mild Cognitive 
Impairment? 
2. What are the disadvantages? 
 
Closing questions 
1. Is there anything you feel we have not discussed that you feel is relevant? 
2. Are there any areas you feel are too difficult to discuss? 
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Appendix 2.6: Sources of Support 
4/7/2014 Version 1 
 
RHAGLEN SEICOLEG CLINIGOL GOGLEDD CYMRU 
NORTH WALES CLINICAL PSYCHOLOGY PROGRAMME 
 
Sources of Support Information Sheet 
 
Should you wish to talk to someone regarding what we’ve discussed today, there are a 
number of people you can contact. 
 
You can talk to your GP, who may be able to refer you to a counsellor within the clinic 
should you wish. You could also speak to the clinician who informed you about the study. 
 
There are also a number of organizations that provide confidential support and information: 
 
Samaritans 
08457 909090 – 24hours a day 
http://www.samaritans.org/  
 
Age UK Information & Advice 
0800 169 6565 – 8am to 7pm 
http://www.ageuk.org.uk/ 
 
Alzheimer’s Society 
01248 671137 
http://www.alzheimers.org.uk/ 
 
MIND – a mental health charity 
0845 766 0163 – 9am to 5pm 
http://www.mind.org.uk/ 
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Appendix 2.7: Sample Interview Transcript and Analysis  
 
Bold: said with emphasis/louder voice. Italics: said softer/quieter/under breath. !: vocal intonation became higher. 
(.) noticeable breathing space, (..) 3-5 second pause, (…) more than 5 second pause. 
Underscore: indicating text referred to in findings. 
 
Sections have been removed for readability. 
 
Coding Transcript interview with Margaret Findings 
 
 
 
 
 
MCI  
 
 
 
 
 
 
 
Interviewer: Okay. Urm so I’d like to talk to you today about 
your experience of your diagnosis of mild cognitive impairment. 
Urm and I was just wondering if you could tell me, to start off 
with, what you think mild cognitive impairment is? 
 
Margaret: (.) I think (.) it’s ur (.) the way it’s affected me is that 
(.) I’m not remembering, facts from (.) from the present. There’s 
a lot I can remember from the past, and so I’m forgetting names, 
even though I know the person that I’m talking to so well. And I 
can start a conversation and forget (.) just where the things 
going, sometimes. [Okay] And um it’s very funny because my 
husband suffers from the same so we tell each other long stories 
but we can usually fill each other’s gaps up! [Oh right ok] But 
 
 
 
 
 
Hesitant, uncertain, does not know what to say. 
“me”, “I’m” – Personalising. 
 
 
Emphasis – surprise? 
“funny” implying humorous or strange? – minimising? 
“suffers” – it is a problem. 
Something is missing? Part of something bigger? 
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Expertise 
 
 
 
 
 
 
 
Ageing 
 
 
 
 
 
 
 
 
it’s very funny when there’s somebody else there. [Yeah] So uh 
it’s it’s an impairment of of ones previously (.) reasonably bright 
intellect, it’s as simple as that it it’s. I used to be able to (.) go off 
into all sorts of detail (.) even sit exams, and yet here I am now 
and I’m fumbling about trying to remember words and names. 
[Yeah] So that’s how it works for me.  
 
Interviewer: Yeah. You urm just said a moment ago about 
impairment of your intellect, so is it affecting more than just your 
memory, are there other parts that you think it’s affecting? 
 
Margaret: Well it causes me to feel quite unhappy sometimes (.) 
that I’ve lost that edge that I think I had. You know, that I just 
feel that I’m a silly old woman sometimes, that I just can’t, be as 
bright and forthcoming as I was. I’ve got three daughters (.) and, 
we used to have such lovely conversations, and we still do 
because they know they can fill in the bits and pieces but (.) I just 
think sometimes that life’s got a bit less (.) urr (.) enjoyable in 
that sense. [Right, okay] Although they tend to talk about fashion 
and that things, which I joi don’t join in with anyway 
(Interviewer laughs). They’re three lovely girls. 
 
“funny” – repetition.  
Externalising. 
No other words. 
 
Contrast to previously “reasonable bright intellect”. 
Active. 
 
 
 
 
 
 
Something/a part of her is lost. 
Will not be taken seriously – societal view of old people?  
 
 
 
Hesitation – uncertainty vs emotive. 
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Ageing 
 
 
Death/dying 
 
 
 
 
 
 
 
 
 
 
Expertise 
Dementia 
 
 
 
Interviewer: Yeah. Yeah. Urm, so in what ways has it affected 
you on a day to day basis? 
 
Margaret: On a day to day basis? (.) It hasn’t, it hasn’t really, no. 
[Okay] No the days come and go, there’s (.) no it hasn’t really 
affected me at all, not that side of things it hasn’t. No. [Yeah] (..) 
And there’s a constant feeling of being at the end of my life now, 
I’m very aware that I’m 77, and that (.) ur I’ve got to really enjoy 
every single moment of what’s left, cos I’m, ha, happily married 
and I’ve got a lovely family, just keep thinking I’m going to have 
to leave them all one of these days, sooner rather than later. That 
comes into my everyday feelings. [Okay] A lot. [Yeah] Quite a 
lot.  
 
Interviewer: Yeah. So has having this diagnosis of mild cognitive 
impairment almost emphasised that a little bit or? 
 
Margaret: Well in a sense it was a bit of a relief cos I I already 
knew that it was that I was suffering from it. [Okay] I’d read a bit 
about it and I already felt that’s where it was going. [Okay] But 
um (.) so many of my friends (.) and people that I talk to, they’re 
suffering in the same ways so it’s become a bit of a joke really 
 
 
 
Repeating, clarifying. 
Does not finish sentence. Repetition “no” – emphasis vs unsure. 
Two sides? 
Implying impending death – unspoken? 
“got to” – not a choice? Imposed/expected of her by others. 
 
Euphemism – Impending death. 
Ageing and death – more important, given more space to think 
about than MCI. 
 
 
 
 
 
“already knew” – she is the expert on her own wellbeing. 
“it” – nameless – what is it? “suffering” – illness discourse. 
Repetition of “it” – emphasis. 
 
Repetition of “suffering”. 
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Expertise 
 
 
 
 
 
 
 
MCI  
Expertise 
 
 
 
 
Dementia 
 
(laughs). [Right] Yeah it has. So I just tend to accept it, what can 
you do? [Yeah] I do lots of puzzles and read a lot and that helps.  
 
Interviewer: Yeah (.) so had you heard about mild cognitive 
impairment. [Yes] before you went to the memory service?  
 
Margaret: Oh yes.  
 
Interviewer: Oh right okay. 
 
Margaret: Yes I have, yes I had heard about it. 
 
Interviewer: Where had you heard about it? 
 
Margaret: Well (.) I suppose (.) from way back in my work and 
all the rest of it. You know as a (PROFESSION) I knew a lot 
about, when I visited the elderly I was aware of of what it was 
and what was going on with them. [Yeah] (.) Yeah so yes I had 
heard about it, I knew what it involved. [Yeah] Just a, just a bit, 
anxious about how quickly it, it proceeds. [Yeah] And how much 
worse it can get. (.) And that awful word Alzheimer’s looming 
up. [Yeah] All the time. Because I had a, my grandmother on my 
Quiet – resigned? 
Rhetorical or wants answer from an expert? Powerless. 
 
 
 
 
Certainty. 
 
 
 
Repeating – certain, but no other words. 
 
 
 
Pauses, vague, unsure. Contrast to above – becomes less certain. 
Vague, unsure. 
Expert – knew from her work vs uncertain – repetition, not 
finishing sentences. 
Repetition – emotive and uncertain about whether to say, 
whether to name?  
Description of medical diagnosis. Labels are powerful and evoke 
powerful connotations. “looming up” – growing, getting bigger. 
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father’s side and his sister suffered from Alzheimer’s, and I 
remember how they were and how it affected them.  
 
Interviewer: Yeah. So is that something that’s playing on your 
mind at the moment? 
 
Margaret: Urm (.) from time to time I remember it and think 
about it. But I try to avoid thinking about it. 
 
Interviewer: Okay. Yeah (.) how do you manage to avoid 
thinking about it? 
 
Margaret: Well (.) those sort of thoughts can make you feel quite 
miserable and so (.) I’m still looking at it, we go out a lot and we, 
we run a club for old people. [Oh right] A weekly club. [Yeah] 
And that takes up a lot of the interest in our lives. Urm and 
several of those ladies, they tend to be all ladies because it’s a 
whist club.  
 
Interviewer: A?  
 
Margaret: A whist, whist drive, sort of a whist drive? You know, 
“suffered” – word linked to dementia/illness. Used several times 
before. 
 
 
 
 
Tentative. 
Avoid – active effort. Does think about but does not want to. 
 
 
 
 
 
Cannot hide from it, getting closer. Outsider looking in. 
Repetition of “we” – not alone, positioned self within a group. 
No space for MCI, dementia, illness. 
“they” – separating herself – does not identify herself as an old 
lady? 
 
 
 
She’s the expert – has the interviewer not heard of a whist drive? 
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haven’t you heard of?  
 
Interviewer: No I haven’t.  
 
Margaret: The card game whist.  
 
Interviewer: Oh yes, yes I know what you mean now. Yeah. 
Okay.  
 
Margaret: So we run it as a little whist group, we’ve been 
running it for 12 years. [Yeah] And we’ve seen a lot of our (.) 
urm members declining over those years and we’ve lost a few, 
through death and um (.) but the ones that go are very happy to 
be there. [Yeah] And enjoy it (.) and we enjoy it too. [Yes] So I 
suppose that’s one way that you’re aware that as people get 
older, they lose that edge, you know that (.) but it doesn’t seem 
to worry them too much we’ve got two 90 year old. [Oh yeah] 
Bright 90 year olds (.) [Yeah] So it seems to take people in 
different ways. I think mines the very gradual way, perhaps, I 
don’t know. 
 
Interviewer: Do you mean the way to d dementia? 
 
 
 
 
 
 
 
 
 
“little” – no space. 
Hesitant about what to say, how to say it. 
“declining” “lost” – in number or cognitively?  
No words. 
Separating herself from others in the group. 
“you’re” “they” – not her – separating herself again. 
“that (.) but” – does not finish sentence. 
“them” – separating when talking about decline vs “we’ve” – 
including herself when talking about “bright 90 year olds”. 
“it seems to take people” – nameless – lose people? 
Own perception of prognosis reduces in certainty. 
 
Hesitation – unsure whether to name “it”? Dementia unspoken/ 
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Margaret: Yes. Yes. I think so. You can stave it off if you, you 
know if you keep active and all the rest of it. The newspapers are 
full of how to avoid it anyway, aren’t they? We get lots of urm 
(.) advice how to avoid dementia.  
 
Interviewer: Yeah. Do you do any of those things that you’ve 
read in the papers? 
 
Margaret: Well yes, you know it’s all about diet and exercise, 
and getting out and about and meeting people and having lots of 
interests. Yes we do, we do do all those things. 
 
Interviewer: Is that in an active effort to, as you said, stave off 
dementia or are those things that you would just do anyway? 
 
Margaret: I think they’re things we would do anyway aren’t they. 
[Yeah] So yes (.) but you know we were talking about, see this 
whole (.) what’s it called again?  
 
Interviewer: Mild cognitive impairment?  
 
not spoken about/hidden away? 
“You” – externalising. “stave” – fight against. 
Vague, lots of ways to “stave” it off? 
Who is the expert? Margaret, newspaper or interviewer? 
“advice” – not definitive, opinions. 
 
 
 
 
 
 
“we” – inclusive, who? Do those things but does not seem to 
work? Do those things already? 
 
 
 
She has the expertise – already doing those things. 
 
Unsure, has not got the words. 
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Margaret: Yeah it’s not that so much, but what (NAME)’s been 
doing, this mindfulness. [Oh right] Yes well I try to use that 
when I start getting these urm feelings and unhappy thoughts. 
[Yeah] Urr but I don’t find that it helps all that much sometimes. 
You know I try to concentrate on my breathing and all the rest of 
it, but it works for a few minutes and then it all comes back. Best 
thing for me is to get in my in my car and go to (PLACE) or 
somewhere. [Yeah] And talk to everybody. And that gets rid of 
it.  
 
Interviewer: Yeah. Yeah. So getting out and about?  
 
Margaret: Definitely is is it’s the best policy for me. [Yeah] And 
that’s why it’s so hard for people who are housebound, it must be 
dreadful. 
 
Interviewer: Yeah (.) so what prompted you to go to the, was it 
the memory clinic or was it your GP to start with? 
 
Margaret: Yes it was the memory clinic. Because (.) I’d noticed 
that my memory was getting worse and worse (.) so I asked Dr 
(NAME), about it and she referred me. [Right] So I’ve been 
 
 
 
Expert does not know/have the answer. 
 
Cannot be stopped. 
She is the expert, she knows what she needs. 
Something unwanted. 
“it” – nameless. 
 
 
 
Definite, decisive, followed by repetition – knows what she 
needs but is difficult to do? Does not always work? 
Unspoken. 
 
 
 
 
She knew, she had the knowledge. 
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going for a while.  
 
Section removed. 
 
Interviewer: (.) Yeah okay. Urm do you, has having mild 
cognitive impairment affected your ability to do mindfulness do 
you think or to do meditation, has it impacted on that? 
 
Margaret: Oh no. [No] No it hasn’t at all. [Yeah] No that doesn’t 
work that way at all. [Okay] I think we tend, I think sometimes 
we meditate more often than we realise, you can you can perhaps 
just sit down and look out at the garden and perhaps just drift off 
into a meditative state you know, (.) so I think we do more of it 
than we realise. [Yeah] But (.) the anxiety thing, it doesn’t seem 
to work. [Yeah, okay] (.) As we’re doing this chatting thing 
(laughs) I’ll, I might as well just say that one of the worst things 
for me is animal cruelty, I can’t bear it. And often when you’re 
out and you see a dog perhaps being (.) badly treated and (.) it 
absolutely gets me (.) and then I try to use the mindfulness thing. 
If I can’t intervene, and usually you can’t, (.) cos it’s across the 
road from you or something, that’s one of the worst things for 
me.  
 
 
 
 
 
 
 
 
Repetition of “no” – insistent that MCI has not affected her 
ability. 
 
 
 
Not got the right words to describe what she means – vague. 
Implied expectation that it should work. “As” – as an aside, 
something that’s related? 
 
Frequent pauses but fluent content – emotive.  
 
Helpless/lack of control/lack of power. 
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Interviewer: Yeah. Yeah. So if some things really get to you. 
 
Margaret: Yes very badly.  
 
Interviewer: And you try to use mindfulness and sometimes it 
helps and sometimes it doesn’t. 
 
Margaret: Yeah that’s right. Yes. It does. 
 
Interviewer: Yeah (.) okay. So do you remember being told about 
your diagnosis of mild cognitive impairment? 
 
Margaret: Yes, it was (NAME) that told me. [Okay] Yeah 
(NAME) told me, the doctor didn’t. 
 
Interviewer: No. So you had the assessments at the memory 
clinic?  
 
Margaret: Yes.  
 
Interviewer: So you had some tests to do.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expected the doctor to tell her? Doctor viewed as more of an 
expert then who did tell her? 
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Margaret: Yes I did. [Yeah] She (.) I was quite amazed at what it 
showed, because one the major things was that there were four 
pictures. And you to, look at those pictures and then explain (.) 
what the people in the picture were doing. I couldn’t do it! I just 
couldn’t do it! I couldn’t even remember who was in the 
pictures! [Yeah] Except that I ur I recognised was a family and a 
dog there. [Yeah] So that amazed me, that I couldn’t do that (.) 
but I can remember ur lists of words, and I can, I can do that. 
[Yeah] So that was a real shock. 
 
Interviewer: Okay, so did you find out that different parts of your 
memory were affected or weren’t affected? 
 
Margaret: Yes. That’s right. Yes definitely, there were bits that 
were and bits that weren’t.  
 
Interviewer: Yeah. Urm what was it like being told that you had 
this diagnosis?  
 
Margaret: (.) Urm.  
 
 
Change of perspective. 
 
 
Repetition “I couldn’t” – emphasis, shock, unexpected. 
 
 
 
Repetition “I can” – contrast to above. Moves from past to 
present – focus on the here and now? Distancing self from 
diagnostic process.  
 
 
 
“bits” – not part of her, detached. Implies small, minimising? 
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Interviewer: If you can remember?  
 
Margaret: It was a little bit, shocking I suppose in a way (.) but 
just a month ago I was told that I had cancer, so. [Oh gosh] You 
just think to yourself, which is worse you know. It’s all part of 
old age. It’s the old vehicle, you know (.) having problems in its 
different parts I suppose. [Yeah] So (.) compared with that 
diagnosis, the mild cognitive impairment one, ur wasn’t quite in 
that league. 
 
Interviewer: (.) What do you think the differences are between 
the two diagnoses, why whys it changed your opinion?  
 
Margaret: Well its urm (.) well its whether it involves lots of 
treatment and constant visits to the hospital, and feeling that you 
know (.) definitely on the way to the end now. I suppose with 
mild cognitive impairment, there were things that you can do, 
you can read, which I love reading an, and watch (.) dramas on 
television. (.) It doesn’t feel as severe, as Alzheimer’s yes it 
would be. We’ve got a friend, younger than us, and his wife got 
it and he’s lost her completely. She doesn’t know who he is and 
they were such a happy married, couple. [Yeah] And, terrible 
 
 
Conflict – minimising the amount of shock? She already knew? 
 “but” – something else more shocking, in contrast. 
“all part” – making sense through normal ageing, expected. 
Machine metaphor – more familiar discourse to make sense. 
“that” – cancer emphasised but nameless. 
League of illnesses. 
 
 
 
 
 
Repetition – time to think, unsure. 
“constant” – enduring, taking over identity/life. 
Death implied, not said. 
 
“you” vs “I” – moves from detachment to personalising. 
Alzheimer’s is viewed as severe. 
Less expected in younger people? 
She has gone, her identity has gone. 
No longer happily married. 
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grief that has affected him. He’s lost her, he feels completely (.) 
whereas with the diagnosis of cancer then, the chances are that 
you still retain a lot of your memories you know an (.) and you 
recognise your family and that stuff, I suppose. 
 
Interviewer: Yeah. I guess it doesn’t affect you as a person, what 
your personality is, [That’s right] it doesn’t affect you intellect?  
 
Margaret: Yes that’s what it is.  
 
Interviewer: You still stay the same person.  
 
Margaret: You do. [Yeah] Well I think you do, I haven’t been 
there yet quite but I think you do. [Yeah. Yeah] It’s just this 
awful long haul down to (.) old age isn’t it and death (.) you sort 
of think how nice it would be if you could just sort of press a 
button and say right that’s it I’m going, and there’s a lot of that 
of course in, in the press isn’t there. [Yeah] When I was, a lot 
younger I didn’t think along these lines. But now I’ve reached (.) 
this age (.) I suppose (.) I think about it quite a lot.  
  
Interviewer: Mmm (.) yeah. Do you ever speak to your family 
Repetition. 
Comparing with other illnesses – making sense of what factors 
affect severity? 
“recognise” – still known. “I suppose” – weighing up. 
 
 
 
 
 
 
 
 
Reduces in certainty.  
“yet quite” – aware positioning is close, trying to distance self. 
Negative imagery – long hard journey, like ageing?  
“death” – explicitly stated. “you” – detachment. 
Implied assisted dying. 
“press” – media influences. 
Repetition “I” – contrast to “you”/detachment above – taking 
ownership of what she had said before. 
Pauses, but fluent content – well-formed discourse, emotive. 
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about this? 
 
Margaret: Urm (.) a little bit but (.) no I’m far too busy listening 
to what they’re telling me. But a little bit I suppose. My youngest 
daughters a (PROFESSION) and she and I talk about these 
things quite a bit.  
 
Interviewer: Okay. Yeah. (.) Urm with your youngest daughter 
being a (PROFESSION), did she suggest that you should go to 
your GP about the memory problems?  
 
Margaret: No. No. [No okay] No, she didn’t. 
 
Interviewer: Do does your family, so your daughter’s, do they 
know about your memory problems? 
 
Margaret: Yes they do.  
 
Interviewer: Your diagnosis?  
 
Margaret: Yeah. [Yeah, okay] It doesn’t seem to make any 
difference to them at all.  
 
 
Repetition “little bit” – can only tolerate a little? 
No space to talk, cannot be tolerated, younger generation 
discourse is louder. 
Her daughter is the expert? 
 
 
 
 
 
Repetition “No” – definitive. Her choice. 
 
 
 
 
Short clipped sentences when asking about family’s views. No 
shared discourse built – if do not share then no discourse? 
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Interviewer: No?  
 
Margaret: Because we we don’t dwell on things like that. You 
know. [Yeah] (.) We have lots of other interesting things to talk 
about.  
 
Interviewer: Yeah, okay. So were they not surprised when you 
got this diagnosis? Or was it just I’ve got this diagnosis and 
that’s that and moved on from there? 
 
Margaret: Well the diagnosis of this, its minor isn’t it. Its its, you 
know, I mean the chances are that it’s not going to get any worse 
because (NAME) did a, when I first met her she did a uh the test 
and then a year later she did the test, and she said if anything it’s 
got slightly better in parts. [Okay] So that was reassuring. So I 
don’t see that diagnosis as really being anything to worry about. 
[Yeah] It’s just, it’s just something that happens as you get older. 
[Yeah] And lots and lots of people live with it, and there are all 
sorts of ways of dealing with it. So no, I don’t see it as a, as a 
major problem.  
 
 
 
 
Repetition “we” – emphasis – her as part of her family. 
Hierarchy of discourses – what is more prominent? Younger 
generation discourse? 
 
 
 
 
 
“minor” – comparisons. “isn’t it – rhetorical, seeking agreement. 
“Its its” “a,” “a uh” – repetition, stop start sentences – uncertain? 
 
 
She’s the expert. 
“that” – in comparison to other diagnoses. 
Justifying, inevitable. Positioned within normal ageing. 
Emphasis, MCI is common.  
 
“major” – contrast to “minor” above. 
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Interviewer: No, no. Do you know what the urm prognosis is for 
mild cognitive impairment, so what the outcomes might be in the 
future? 
 
Margaret: Well no because I haven’t had that conversation so I 
don’t know. I’d be quite glad if you’d tell me actually (laughs). 
 
Interviewer: Yeah, I’ll tell you what, I’ll tell you towards the end 
[Towards the end] of the interview. [Okay] Yes I will go 
through. [Yes] I will go through that with you.  
 
Margaret: And how to spot when things are going worse, because 
I don’t think I know that really.  
 
Interviewer: Yeah. So have you been tested twice then by the 
memory service?  
 
Margaret: Yes. [Okay] Yes and I think they’re going to test me 
again, a year from the last time. [Yeah] I’m hoping they will 
anyhow.  
 
Interviewer: Yeah. My guess is that you probably are on that 
 
 
 
 
Conversation with an expert. 
Putting researcher in expert position. 
 
 
 
 
 
 
Tentatively putting interviewer in expert position – not sure if 
she does not know?  
 
 
 
“they’re” the experts, the memory clinic. 
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waiting list to be reassessed in a year’s time.  
 
Margaret: Yes I think so, yes I will be. [Yeah] That’s common is 
it to be tested every year sort of thing?  
 
Interviewer: Yeah. So how do you feel about being just put on 
this waiting list to just be tested every year? 
 
Margaret: It’s reassuring to know that somebody’s keeping an 
eye on you. [Yeah] It means that you know, at some point you’re 
going to be shown (.) whether you’re just as you were or you’ve 
you’ve got worse. [Yeah] So it’s sort of an official recognition of 
where you are. 
 
Interviewer: Yeah. So you don’t feel worried about the testing 
coming up, you know when you get the appointment letter 
through? 
 
Margaret: No, absolutely not. I quite enjoy it (laughs)! 
(Interviewer laughs) [Oh okay!] Yes I do. 
 
Interviewer: Yeah. And have you spoken to people outside your 
 
 
Unsure, becomes more certain. 
Putting interviewer in expert position. 
 
 
 
 
Surveillance. Somebody else is the expert. 
Repetition “you” – distancing/externalising. 
 
Power? Makes diagnosis official and legitimate. 
 
 
 
 
 
 
Certain, definite. 
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family, so friends, about this diagnosis of mild cognitive 
impairment? 
 
Margaret: I’ve not actually mentioned the diagnosis, just simply, 
just simply chatted (.) generally about what a pain it is when you 
can’t remember names and (.) especially in our little club, we’re 
always talking about it, but they can all play a good game of 
whist! (laughs) So you know that are a few there that sort of say 
oh I can’t remember what I was talking about and I’ll say well 
that’s just how I am, we’re all the same you know! And that 
gets over that, that’s fine. It’s like a sort of urm supportive little 
group in that sense. [Yeah] While they’re busily playing cards 
they’re telling you all these things that affect them, so that by 
sharing it it helps a lot. [Oh okay. Yeah] So sharing worries. But 
we don’t use words like mild cognitive impairment. [No] No. We 
don’t use those words. 
 
Interviewer: What words do you use? 
 
Margaret: (.) Just we, I can’t remember so and so’s name when I 
meet them, and you know (.) I I went to the shops and I couldn’t 
remember what I’d come for and I go upstairs and I get to the top 
 
 
 
Would normally share with friends? 
Repetition, pauses – unsure what to say. 
 
What is “it”? “but” – minimising previously mentioned 
difficulties, can still play whist. 
 
She’s no different to them, included, part of social group. 
Implied that there is something to get over? Something difficult 
implied in the conversation/discourse of forgetting – dementia? 
 
Sharing helps – but does not share MCI. 
These words hold no meaning. 
 
 
 
 
Pauses – unsure of what to say, how to answer question. 
Moves from “we” (group) to “I” (self) – uses herself as an 
example because MCI is not spoken about. 
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of the stairs and I can’t remember what on earth it was I came 
upstairs for, things like that.  
 
Interviewer: Yeah. So you talk about how it practically affects 
you. [Yes] In your day to day lives. [Yes] So you know, the 
things that you forget. 
 
Margaret: And it so doesn’t matter. You make lists more than 
you used to. Lists are very useful aren’t they?  
 
Interviewer: Yeah. So is that something that you do then to help 
you with your memory problems? 
 
Margaret: Yes, we’ve got a notice board in the kitchen which 
tends to have all the bits and pieces on it that we need to 
remember, an. [Yeah] You know, although I’ve just been to see 
what the doctors su (.) what practice my doctor is in and I can’t 
even find that on the board so that must’ve been thrown away at 
some point.  
 
Interviewer: Yeah. So is there anything else that you do to help 
with your memory problems? 
Said with emphasis – surprise, emphasis on effects on MCI. 
 
 
 
 
 
 
“so” – emphasises. Uses list example to minimise problems. 
Pull in, include the interviewer – Margaret already knows the 
answer, she is the expert. 
 
 
 
“we’ve” – her and her husband, part of a group, included. 
 
Exception, notice board does not always work. 
 
“even” – surprised, should be able to find it. 
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Margaret: Urm (.) yes I do crosswords. [Yeah] And urm (.) I 
don’t do them because of that, I do them because I enjoy doing 
them so (.) I don’t think I’ve got too much to worry about at the 
moment, its it is very mild whatever it is. [Yeah] I know it’s 
probably going to get worse, but so what, you know. There is, 
there are various things they can do aren’t there, aren’t there 
medications, medication that you can take? [Urm] That might 
help?  
 
Interviewer: Yeah there is for Alzheimer’s, yes. [Yes] Yeah (.) 
Urm (.) it won’t nes it won’t make it better but it can stop it 
deteriorating as quickly.  
 
Margaret: Yes. And you sort of wonder, at what point, you know 
you’ve got Alzheimer’s rather than you know a bit of senile 
dementia, what where is the cut-off point.  
 
Interviewer: Yeah, what do you think the cut-off point is? 
 
Margaret: Well I don’t know, I don’t know really. (.) Now that 
would worry me, that would worry me very much. (.) I’m not 
 
 
“that” – MCI/memory problems not named. 
Implied there is something to worry about. 
Unknown, no words – MCI does not mean anything. 
Said quietly – difficult to say, does not mean what she says? 
“they” – who? Who are the experts? 
Interviewer as expert. Asking for reassurance. 
 
 
 
 
 
 
“you” – detaching . 
“bit” – can just have a small amount? 
Which story to tell – ageing vs dementia. 
 
 
 
Repetition, said quietly, pause – time to think, uncertain. 
“me” “I’m” – personalising. 
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sure (.) perhaps there isn’t a cut of point, perhaps there’s a 
gradual deterioration, I don’t know. (.) I’ll ask you at the end 
(laughs). 
 
Interviewer: Urm and what do you think has caused the mild 
cognitive impairment, do you have an idea of what you think 
might’ve caused it? 
 
Margaret: I think it’s just part of of getting older. [Yeah] We’re 
all living a lot longer now aren’t we? But also the fact that it’s in 
the family as well. [Right] It seems to be in the female side of my 
father’s family I think. [Yeah] Because he was as bright as a 
button when he went and so was my mum. But it might be the 
female side, so I’m in direct line aren’t I from Granny to Auntie 
to me. And so I start thinking along those lines. There’s a lot 
being written about it, and I tend to read it if I see it in the, 
particularly in the newspapers you see, articles about it, I read 
those (.) but I try not to think about it too much. 
 
Interviewer: Yeah. Yeah. (.) Okay, and how did you think about 
yourself before the diagnosis of mild cognitive impairment? How 
would you have described yourself? 
Offering an alternative answer. 
Putting interviewer in expert position. 
 
 
 
 
 
 
Minimising – normal. 
Inescapable. 
Genetics – cannot change prognosis, inescapable. 
 
 
 
 
Written word is powerful. 
Media influences. 
Contradiction – does vs does not want to know. 
 
 
 
 
Appendix 2.7  
227 
 
 
MCI 
 
 
 
 
 
 
 
 
 
Hierarchy 
of illness 
 
 
 
Ageing 
 
 
Hierarchy 
of illness 
 
 
Margaret: Well (.) just quite capable of (.) of remembering facts 
and (.) holding a decent conversation without having to think 
now where did I see that or whose name was that or. It’s harder 
now to chat with people, especially when you don’t know them 
too well (.) although I’m not doing too badly with you, am I? 
(laughs).  
 
Interviewer: No, not at all (laughs).  
 
Margaret: No, so it hasn’t really made that much difference. (.) 
There’s so many other things to worry about.  
 
Interviewer: Yeah. Do you think of yourself any differently now, 
compared to before you had the diagnosis? 
 
Margaret: (.) Yes I think do. I used to be able to whizz through 
my life, you know whizz through the housework and go to work, 
and see the family and now everything slowed down very much. 
[Yeah] But that might because there’s an underlying depression 
there too I think. Which, I’ve got tablets for that, (.) I but think 
everything’s slowed down so much and (.) arthritic pain doesn’t 
 
Now not as capable?  
Pauses – difficult to articulate? 
 
Past vs present – changes. 
Bringing interviewer into conversation, seeking reassurance. 
 
 
 
 
Changes perspective to above – does vs does not affect her. 
“other things” – other more concerning illnesses. 
 
 
 
 
“whizz” – speech is fluent, continuous, paced. 
 
Talks about slowing down – speech begins to slow down – 
frequent pauses, contrast to above. 
 
“slowed down” – reflected in speech. 
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help either (.) it’s the tendon (.) um. (.) You’re much less 
efficient at things, even (.) cooking, you know, becomes an 
absolute (.) burden sometimes, you know, but I’ve got a husband 
who enjoys cooking and he’s just made 18 pans of marmalade 
(laughs). 
 
Interviewer: Gosh! (laughs) That will keep you going for a 
while!  
 
Margaret: (laughs) Yes well we give a lot of it away. But he 
loves doing things like that, that’s a great blessing. He’s out 
walking at the moment, he’s the same age as me, 77 and he’s got 
a walking friend and he’s got a friend he goes to air shows with 
and, he’s very positive, and (.) [Yeah] he makes everything a lot 
easier. [Okay] Yeah he does.  
 
Interviewer: Yes, so he’s quite supportive? 
 
Margaret: Very supportive. Yes, he’s fantastic. [Yeah] So lucky. 
And how long have we been married now (.) urm, I think its 35 
years now we’ve been married. [Yeah, wow] And urm I’m just 
so lucky to have him. [Yeah] (.) His ears’ll be burning!  
 
“even” – the changes are unexpected. 
 
 
 
 
 
 
 
Minimising how long it will keep them going for – will not be 
around for that long? 
Alternative ageing discourse – not slowed down like her. 
 
Everything is now harder. 
 
 
 
 
Implied others not so lucky. Putting husband in position of 
responsibility – she is dependent on his support. 
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Death/dying 
 
 
 
Interviewer: (laughs) Yeah. Urm, so, do you talk to him about 
the mild cognitive impairment? 
 
Margaret: Yes, yes, sometimes. But his his way of looking at it 
is, don’t worry about it, it’s fine. [Yeah] You know, we’ll deal 
with it, its fine, and that’s his way of looking at everything really. 
[Yeah] He does worry about things like the garden. See I used to 
love the garden, when we moved here 25 years ago, I had 
greenhouses full of tomatoes and I had a lovely vegetable garden, 
and , and now it’s it’s really hard work to do it, so I’ve  filled it 
up with shrubs and lawns and trees. [Yeah] There’s half an acre 
out there you haven’t seen have you?  
 
Interviewer: No. Gosh.  
 
Margaret: And it’s a big garden. We had hens when we came 
here. [Yeah] And we thought of having a goat (.) and it’s all gone 
now, you know. And you see now our children have those sort of 
ideas. And you think to yourself life goes so quickly so get on 
with yourself, go do it. Do it while you can. One of them’s just, 
she’s got two horses now. [Yeah] And (.) she’s filling her life up 
 
 
 
 
 
No space to talk about/husband does not want to talk about it 
either – no space to talk about MCI. 
Past tense – no longer? Things are changing. 
 
 
 
 
 
 
 
 
 
Discourse of loss. 
Younger generation taking over. 
Advice to younger generation – wisdom.  
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with animals, she’s like me.  
 
Interviewer: Yeah, very much taking after you then on the animal 
front?  
 
Margaret: Well. Yeah, I think with all three of them they’re all 
very different personalities but (.) I can see me in lots of things 
that they do. [Yeah] (..) I think that’s, I think somebody who was 
perhaps alone and didn’t have family and friends, they would 
suffer terribly as they began to lose (.) names and (.) places, but 
(.) it’s it’s so different when you’ve got a fairly full life. [Yeah] 
They’re all coming next Saturday (.) we’ve got 10 coming for 
dinner. [Yeah]  In this little bungalow! (Interviewer laughs) So 
we’re going to make it easier, cook a few chickens and do a load 
of oven chips, that’ll sort them out (laughs)! [Okay, yeah!] A few 
trifles, and that will do won’t it. [Yeah] But it’s lovely that 
they’re all coming , it’s it’s for (NAME)’s birthday. So (.) see my 
daughters are in their 50s and I think oh goodness! [Yeah] Can’t 
believe it. [Yeah] So I’m looking forward to that.  
 
Interviewer: Yeah. Urm so its sounds like being busy and having 
lots of things to do, keeps you going? 
 
 
 
 
 
 
 
 
Positioning herself in terms of others. 
 
“so” – contrast between her life and others. “you’ve” – 
distancing herself – concerned about how she might be viewed 
by the interviewer? 
 
 
 
 
Surprise – does not fit with how she sees herself? 
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Margaret: It does, [Yeah] it does. And you can switch off as well 
in other ways, is if you’ve got a really good book on the go you 
know you can get into that and stop worrying so much. I’m 
trying to wade through Wolf Hall at the moment. [Oh right, 
yeah] Because of the, because it’s on the television. [Yeah] And 
urm it’s fairly hard going but I like the way she writes, Hilary 
Mantel. [Mmm] (.) See I’m remembering things aren’t I? There 
you are you see. Bring up the Bodies is the next one, I’ve got that 
as well to read. (.) I suppose really you know when you look at 
how your children’s lives are, and how busy they are and 
stressed they get (.) we’re very lucky at this end of our lives 
because we can (.) we can enjoy a lot of things that there isn’t the 
time for earlier. I remember being so rushed all the time, [Yeah] 
and you don’t have to be rushed anymore. 
 
Interviewer: No. Is it quite difficult though adjusting to [It was] 
not being quite so rushed? 
 
Margaret: Ahh when I first retired (.) I I went from somebody 
who, you know, I felt, was important in life, well not important 
that’s the wrong word (.) capable and (.) and then all of a sudden 
 
Being busy allows her to “switch off”. 
“you” – appears to be giving advice. 
 
 
 
More capable than others (like the interviewer?) may think? 
Looking for reassurance – proving to interviewer that she can 
remember? 
 
 
“we’re” – who? Her and husband, her and whist group, her as 
part of older generation/population? 
Wisdom. 
“I” vs “you”. 
 
 
 
 
 
Viewed socially as important, useful. 
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you wake up one morning and you’re just plain old Mrs so and 
so, OAP. [Yeah] That’s I think why we started this group 
because it was a chance to give back a bit of that. Because in 
work I I used to be involved with groups. [Yeah] So it was a nice 
way of giving that back. And there are so many, very lonely old 
people out there (.) but it’s sometimes difficult to get them to join 
a group, you know. [Yeah] They tend to be (.) you have to really 
find them, or someone else finds them for you.  
 
Interviewer: Yeah, yeah I guess if they’re quite isolated. [Yes] 
They won’t know what’s going on, [No] they won’t have the 
[And they’re] the social contacts.  
 
Margaret: And they’re a bit suspicious about things, not sure they 
want to be involved with a group. [Yeah] But we’ve got 18 
members, which is quite a lot really.  
 
Interviewer: Yeah. Yeah. So it sounds like in the past you, kind 
of defined yourself by this job, you had responsibilities. [Yes] 
You had, you had a role, you know, there was meaning wasn’t 
there.  
 
“I” vs “you” – distancing from ageing. 
Nameless, categorised. 
“that” – what does she want to give back? 
 
How old people are viewed by others. 
 
Old age is hidden away. 
 
 
 
 
 
 
 
 
Group is getting bigger – previously referred to as “little”. 
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Margaret: Yes and I had the opportunity to go and really help 
somebody sometimes you know. Just like you’re doing now, 
sitting talking, I used to do a lot of that. Because after a while 
they’d start to tell you about the things that were really worrying 
them. [Yeah] And um sometimes you could help a bit, or even 
just listen, that was the important part of it. [Yeah] And I always 
felt, you’re there to do a (PROFESSION) and (.) and they’d 
finish up telling you what a, you know, a sad life they were 
having with their marriages or whatever. (.) Sometimes you could 
do something and sometimes you couldn’t but you could listen. I 
enjoyed that part of the job, I really did. [Yeah] Really enjoyed 
that. I did miss it, in a way I did miss it. [Yeah] Not as much 
now. (.) The job has changed a lot anyway. [Right] I don’t think 
they go out visiting as much as we did. We used to try and get in 
about 5 or 6 visits a day. [Yeah] And (.) I suppose all the check, 
(PROFESSION), the clinics, and the (.) and the paperwork. So it 
was very busy. [Yeah] (..) [Yeah] So.  
 
Interviewer: (.) Yeah, so it sounds like things changed quite 
significantly then when you retired.  
 
Margaret: They did, yes.  
She used to have opportunity to be meaningful. 
She used to be like the interviewer – she is the expert. 
 
 
 
 
 
 
Said quietly – wants the interviewer to listen closely. Wisdom. 
 
 
Repetition – emphasis. Discourse of loss. 
Younger generation do not do as good a job as her generation. 
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Interviewer: Um, almost a bit of shock, not to be working 
anymore.  
 
Margaret: That’s right. Yeah.  
 
Interviewer: And then did that change again when you had this 
diagnosis that, of mild cognitive impairment or did things just 
stay the same? 
 
Margaret: Just stayed the same. [Yeah] I can’t honestly say that I 
think about it very much. [No] You know, I don’t see it as a 
problem. But then again I haven’t gone into what its likely to 
become in the future, I don’t know enough about that part of it (.) 
urm (.) so I (.) I think the other diagnosis has probably given me 
more [Yeah] cause for worry, you know. Although they’ve been 
very reassuring about that as well so (.) (laughs). [Yeah] (.) No, 
I’m not worried about not worried about this other thing at all.  
 
Interviewer: No. Okay. So do you think there are any advantages 
to knowing that you have mild cognitive impairment? 
 
 
 
 
 
 
 
 
 
 
 
Emphasising that she does not think about it, it has not changed 
her life. 
Changing her position/justifying why she does not think it is a 
problem.  
 
 
Reassuring about MCI diagnosis too. 
MCI is nameless. 
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Margaret: (.) Urm. In a way yes. In a way it sort of helps to have 
a diagnosis doesn’t it. When things aren’t going (.) quite right 
and you’re thinking why on earth can’t I remember like used to 
be able to, it’s it’s good to have a diagnosis you know where 
you’re going, you know what’s happening to you. [Yeah] And, 
it’s a common thing isn’t it, so many people, of my age have got 
(.) a bit of it, or a lot of it. [Yeah] So it’s not something I’m 
worried about really.  
 
Interviewer: No. No (.) urm you said earlier that your husband 
also has some memory difficulties.  
 
Margaret: Yes he does.  
 
Interviewer: Occasionally and you end up finishing each other’s 
stories. 
 
Margaret: (laughs) Yes yes.  
 
Interviewer: Um, does he have a diagnosis? 
 
Margaret: No he hasn’t.  
Biomedical discourse – diagnoses are helpful. 
Tentative phrasing. 
 
Benefit of having a diagnosis is for prognosis – however does not 
know/have clear prognosis around MCI. 
MCI is normal ageing. 
Is MCI a bit of ageing? 
Not worried when MCI is positioned alongside normal ageing. 
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Interviewer: No. Okay.  
 
Margaret: (laughs) The chances of him having one are remote 
because he’s the sort that would say oh no I’m fine.  
 
Interviewer: Yeah. So he wouldn’t go to the GP and talk about 
having memory problems, no. 
 
Margaret: No I don’t think he would. And urm I don’t know 
where he is in relation to mine, but I’d say that perhaps mines 
worse than his. [Right] You know. (.) I tend to put things in 
strange places sometimes you know. Because I’m thinking about 
other things, I’ll just put something down, I loose things 
constantly, that’s one of the biggest things about it. I can’t find 
things, I spend hours looking for things. [Yeah] And ur so I try to 
get really tidy. But (.) the trouble with that is I put things away 
very carefully (laughs). And then I can’t remember where I’ve 
put. [Yeah] So I’ve chucked out all my boxes that you can’t see 
into and I’ve got these plastic boxes now so that I can see right 
away what’s in them. [Yeah] I do a lot of craft. [Right] And urm 
(.) so I’ve got wool (.) I could open a shop the amount of wool 
 
 
 
 
Different “sort[s]” of older people? 
 
 
 
 
Positioning her cognitive difficulties in relation to her husbands – 
hierarchy of cognitive difficulties. 
 
Unusual for her, MCI is “strange”? 
 
“it” nameless – but big impact – MCI is an annoyance? 
 
Her strategies do not seem to work. 
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I’ve got. And material an. [Yeah] And I make things and that’s 
another lovely part of the week. We have a little sewing club on 
a Wednesday morning, and, just a very small group but I really 
enjoy that little group. [Yeah] I think that’s one of the answers, 
just to get out there and join little groups. [Yeah] And I’m, just, 
get involved with things. [Yeah] You know. 
 
Interviewer: Urm (.) are you ever self-conscious that you can’t 
do things as well as maybe you used to be able to do maybe 20 or 
30 years ago? 
 
Margaret: Yes, I can’t I can’t thread needles like I could. And 
there’s a lot of arthritis in my hands that when I knit, I can only 
knit for so long then I have to give up. So I’m aware of that (.) 
but (.) not to any great extent. [No] You sort of, you adapt to 
what you can do. [Yeah] You know I paint as well, I love 
watercolours so I do those. [Yeah] And urm (.) that’s not too 
difficult, you can hold a paintbrush and you can get on with that. 
[Yeah] So no, I just find that time is going so quickly, the weeks 
are just hurtling by. [Yeah] And you feel you want to really 
cherish every moment really. That’s the feeling. [Yeah] (.) And 
the thought of having to leave family one day, that’s fairly 
 
 
“small” “little” repetition – she is small – ageing? Contrast to 
MCI “biggest” – above. 
 
She’s the expert, has wisdom. 
 
 
 
 
 
Repetition – emphasis. 
Arthritis positioned as having more of an affect than MCI. 
“give up” – choice, forced – by ageing. 
(.) but (.) – hesitant, fluent content, emotive. 
Repetition “you” – externalising, what has to be done, choice 
less. 
 
 
Contrast to previous statement “I’ve got to” (p.2) – alternative 
discourse, however “you” detaches, something she ought to say? 
Death/dying implied, not said. 
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horrific as well. 
 
Interviewer: (.) Yeah, so it sounds like there are more pressing 
things on your mind, other than this [Yeah] diagnosis [Yes] this 
is only a very small part of your life. 
 
Margaret: Yes it’s a very minor part. It, because it’s not at the 
level yet. If it got worse, and (.) say I couldn’t drive my car that 
would be a, that would be a big problem because I just love that 
independence. [Yeah] So ur yes. I jus. As things are, if they 
would stay as they are, that would be just fine. [Yeah] That 
would be lovely, I can deal with that, I can live with that.  
 
Interviewer: Yeah, yeah. (.) Urm are there any disadvantages to 
having this diagnosis of mild cognitive impairment? 
 
Margaret: Well (.) not if you try to put it out of your mind. You 
just try not to think about it. [Yeah] You just um get on with it. I 
can do just about everything I want to do and need to do. [Yeah] 
And (.) so I can’t really see any massive disadvantages. [No] 
You, you can’t tell stories about things like you used to be able 
to, but I mean it’s, you know, you go somewhere enjoy a film or 
Emotive language. 
 
 
 
Mirroring Margaret’s language – “small” “little” 
 
“very minor” – emphasising how small. 
“level” – what level? Like a clear cut off point. 
“If” – tentatively considering possibility MCI worsening. 
Stumbles over phrasing – difficult to say. 
 
Making compromises 
 
 
 
 
Considering answer. Goes on to try to justify why no 
disadvantages. 
“you”, then moves to “I”. 
“massive” – in comparison to? Implies still big disadvantages. 
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Dementia 
 
 
you enjoy a play (clock chimes) and you try to recoup back to 
somebody else and you can’t because you can’t remember the 
blummin details you know (laughs). [Yeah] Can’t remember who 
was in it and urm, bits of the story aren’t always there and (.) so 
(.) that’s how it works. [Yeah] (.) I think really I’m probably, 
only a very mild case of it you know. The only thing that worries 
me is what’s going to happen (.) down the line, in a years’ time. 
[Yeah] In two years’ time, is it going to be very much worse? (.) 
I wonder. 
 
Section removed. 
 
Margaret: Yes. And then going onto Alzheimer’s, that’s?  
 
Interviewer: Well Alzheimer’s is a type of dementia.  
 
Margaret: Oh I see of course it is, yes. So you get to the point 
that you don’t recognise people and.  
 
Interviewer: Yeah, some people get to that point, yeah. Urm I 
think with everybody it’s slightly different, you know, the, the, 
what exactly happens.  
 
Emphasis and repetition – emphasising what she cannot do. 
No other words. 
 
She’s the expert, justifying. 
In contrast to “massive” above – shift in description, many 
problems but “only” a mild case– minimising, emphasising. 
Wanting interviewer to take expert role and answer question? 
“worse” – implied dementia?  
 
 
 
Gradual decline. 
“that’s?” – interviewer as expert, looking for answers. 
 
 
Margaret knew the answer? Taking back expert role. 
Does not/cannot continue sentence. 
 
Trying to make distinct between stages of dementia. 
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Margaret: Yes. Okay. It’s such a cruel thing to happen isn’t it. 
You sort of feel that, that, mind you my brothers got Motor 
Neurone Disease, and (.) he’s paralysed, he’s got to be fed by a 
tube, he can’t speak. But his intellect is fine. [Yeah] You know 
like Stephen Hawking, he’s a typical example. [Yeah] (.) I I 
think that must be torture when (.) everybody else. The longer I 
live the longer I realise, the more I realise that most of us have 
got nightmare-ish things going on at some point in the future. It’s 
just part of it. Although some people seem to live, golden lives 
don’t they. [Yeah] Although do you know I think it’s all down to 
attitude as well, if you can sort of say oh right that’s happening, 
so what and go and do something else, you can avoid it. It’s 
dwelling on it that’s the problem. [Yeah] And that’s why I don’t 
dwell on it, I try to, you know (.) avoid it if I can but take any 
advice. [Yeah] Is it still switched on?  
 
Interviewer: It’s still on yes. Urm, so (laughs)  
 
Margaret: That’s the elephant into the room! (laughs).  
 
Interviewer: The voice recorder, yeah (laughs).  
 
“cruel” – used word before in context of animal cruelty. 
“isn’t it”  - bring interviewer in. “mind you” – minimising, 
hierarchy of illnesses. 
 
 
Does not finish sentence – cannot be spoken about. 
Wisdom. 
“nightmare-ish” – not real, like being in a dream/asleep. 
MCI is part of life, part of ageing. 
Bringing interviewer into conversation, looking for assurance. 
 
“avoid it” – like with dementia.  
She is the expert. Knows what she needs to do to avoid worrying 
about dementia. 
 
 
 
 
Like MCI? Like dementia? 
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Margaret: Oh, dear! 
 
Interviewer: Urm so, we, we’re coming towards the end of the 
interview urm I was wondering whether there’s anything else 
that you think might be relevant but that we haven’t discussed? 
 
Margaret: Urm (..) well you know you were talking about 
forgetting where you’re going (.) all my life I’ve found that 
problem! [Okay] (Interviewer laughs). That I can get lost in a 
town quite easily (laughs). [Yeah] So (.) I think that’s happening 
now. I can’t I can’t visualise ur a route and I just wondered if 
that’s something that’s part of you anyway? 
 
Interviewer: Have you ever been able to do that very well? 
 
Margaret: Urm no (laughs).  
 
Interviewer: No, well.  
 
Margaret: So there you are that’s that isn’t it.  
 
 
 
 
 
 
 
 
Tentative – worry.  
 
 
 
 
“you” – distancing due to fear of dementia? 
 
 
 
 
 
 
 
Question has not explicitly been answered – answers it herself. 
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Interviewer: Yeah, it needs to be a change in your abilities. 
 
Margaret: A change, that’s right.  
 
Interviewer: Yeah, so if that, if that was totally normal for you 
and it has been for most of your life then.  
 
Margaret: I don’t need to worry about that too much. [No] No 
and one of, and one of the girls has got exactly the same problem 
(laughs). [Yeah] (Interviewer laughs). So when she and I go out 
together it’s (.) who knows where we’ll finish up (laughs)! 
[Yeah] (Interviewer laughs ) (.) Oh that’s good that was a thing I 
wondered about. But I don’t think it’s getting any worse. He 
tends to do the driving which is a pity really, my cars only done 
seven thousand miles. [Yeah] And I some, he likes to drive and 
that’s part of him so that’s why I’ve been beetled off sometimes 
when he’s on one of his treks, like today. [Yeah] Or later on I’ve 
got a friend lives round the corner and I’ll ring her up, come on 
(NAME), we’re going for a wander. [Yeah] Don’t know where 
we’ll finish up! [Yeah] But you know all those things you can do 
them so long as you can still do those things. [Yeah] I think 
that’s the answer isn’t it. [Yeah] But thank you, you’ve made 
 
 
“change” – using same language emphasis as interviewer. 
“that’s right” – taking back expert role? 
 
Margaret finishes sentence. 
 
Emphasising how little she needs to worry about dementia. 
Minimising general difficulties. 
 
“it’s (.)” – does not finish sentence, changes route. 
“thing” – nameless, not specified. 
She is the expert in her own condition, monitoring her own 
changes. 
 
“part of him” – like forgetting route is part of her. 
 
 
Like with MCI? 
 
She is the expert – wisdom.  
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things a lot clearer. [Okay] I’m delighted to know that one in 
three of us actually gets over this, I can’t see it happening, but if, 
I think I’ve had mild cognitive impairment all my life (laughs)! 
(Interviewer laughs) I can memorise facts pretty well, or I used 
to be able to but. [Yeah] It’s part of my personality (laughs) (.) it 
makes for quite an interesting life. [Yeah, yeah] (.) And also it 
makes you very compassionate for people who are clearly going 
through something, you know, I often go to (PLACE) ur 
(PLACE) market, have a wander round there and I go in that 
little tea room that’s there and, sometimes, the people in there 
you can tell that they’re struggling an. Desperately sorry for 
them, you know. [Yeah] (.) All we can do is just (.) well, 
kindness is the big thing I think. [Yeah] I love my little group, 
and even, you know even on Boxing Day they wanted to meet 
because so many of them are so lonely (.) all I’ve done is talk 
about my group haven’t I, instead of talking about what this 
means! 
 
Interviewer: No no that’s okay!  
 
Margaret: (laughs) Oh good. 
 
 
“us” – now part of a MCI group?  
Minimising. 
 
“part of” – repetition. Is MCI part of her or not? 
Repetition “it” – what is she referring to? MCI? 
 
 
“wander” – used term earlier – like people with dementia? 
 
“they’re” – detaching herself – making comparisons.  
“we” – who? Her and interviewer? 
 
 
 
Unsure about MCI – spoken about group instead.  
 
 
 
 
 
 
Appendix 2.7  
244 
 
 
 
Expertise 
Interviewer: Okay (.) so is there anything else? 
 
Margaret: No [No] there isn’t. [Okay] I’ve found this really 
helpful. [Okay]  Very helpful. 
 
Interviewer: Okay so I’ll turn this off now then. 
 
 
Giving interviewer expert position.  
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Appendix 2.8: Further transcript examples illustrating discourses 
 
Below are further sections of other interviews, not referred to in the text, illustrating the 
presented main discourses. Longer extracts are presented where appropriate to give a flavour 
of the conversations. Some sections can illustrate more than one discourse, but are quoted 
under the most prominent discourse. Texts are not repeated here if they have been presented 
in the text. 
 
Bold: said with emphasis/louder voice. Italics: said softer/quieter/under breath.  
!: vocal intonation became higher. 
(.) noticeable breathing space, (..) 3-5 second pause, (…) more than 5 second pause. 
Underscore: indicating text referred to in findings. 
 
Not Knowing – Mild Cognitive Impairment 
Name Extract of Transcription Findings 
Gwen Well it’s a bit (.) ah, to me it sounds as 
though, how much I understand now, 
you know has it affected my brain 
(laughs), well you know affected me 
[Yeah] me ur stroke. [Yeah] That’s the 
only thing I can think of. 
Stop, start, pause – uncertainty about 
what to say, how to say it – does vs 
does not know. 
Repetition “you know” – she does not 
know? 
Stops conversation. 
Gwen I don’t notice much difference you 
know, I mean if it had affected me 
bodily I would notice it more I suppose. 
[Yeah] But ur, I think my daughter 
(NAME) says I do forget (.) which I do 
forget you know, I tend to have to 
write things down I forget a lot. [Yeah] 
Even easily you know I’ll (.) and then 
I’ll think, and I don’t at all (laughs). 
[Yeah] And then (NAME) will ask me 
something and oh I dunno (laughs).  
MCI not affecting her. 
Affected her mind, not her body. Body 
vs mind – hierarchy of illness. 
 
MCI is affecting her – contrast to above 
– shift in positioning.  
“I do forget” – emphasis – she does 
forget – surprise? 
Disjointed, pauses – what to say. 
Laughs – masking thoughts/feelings, 
minimising impact. 
Gwen Yeah, I suppose. (..) But ur (..) I’m not 
too bad, I don’t, it doesn’t really bother 
Quiet – does not want to agree. 
Pauses, disjointed – does not know 
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me that much but I have to write things 
down or (.) my daughter reminds me 
you know (laughs). 
what to say.  
“but” – implies MCI does affect her, 
moving position. 
Clive … cognitive ur impairment, mild 
cognitive impairment … 
Trying to say phrase right – does not 
say it very often. 
Clive I think I am coping with it now, yes. 
But, as I said (.) from when I finished 
with (NAME) (.) I think it’s gone 
worse. [Right] Because I’m (.) I’m I’m 
forgetting things that I did two minutes 
ago, you know. 
 
Despite coping, something is still not 
right. He is the expert. 
Pauses, repetition “I’m” – difficult to 
say? 
 
Clive I just think about it occasionally and 
that I don’t know what it is. I’ve just 
got to live with it. 
Quiet – drawing interviewer in vs does 
not want to say out loud. 
No choice. 
Andrew If you could speak plain English we’d 
get on better! 
Words do not make sense – jargon. 
Medicalising causing exclusion? 
Andrew Interviewer: And before you were 
given the diagnosis had you heard of it 
before? 
Andrew: (.) T to be honest I don’t think 
so. [No. Okay] Not this short term 
mem, (laughs) being a, being a person I 
had to go short term, it’s still bloody 
memory loss, you know! [Yeah] This 
term short-term seems to disguise it in 
some way you know! 
 
 
 
Pause, repetition – time to think. 
Phrase is unfamiliar. 
 
The term ‘short term’ hides what the 
problem is? 
The language covers it up. 
Jack Interviewer: …So I was wondering if 
you could tell me what you think mild 
cognitive impairment is. 
Jack: Urm, minor loss of memory 
function.  
 
 
 
“minor” – minimising.  
Short answer, cuts off conversation – 
no words. 
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Jack Interviewer: And do you ever use that 
name (MCI)? 
Jack: No.  
Interviewer: No, ju so when you.  
Jack: Just forgetfulness.  
Interviewer: You just call it 
forgetfulness?  
Jack: Yeah cos it’s too complicated that 
name (laughs)! 
 
 
Short, definite answer. 
 
MCI language not accessible – does not 
make sense. 
Clarifying 
Language not accessible. 
Margaret Margaret: …So sharing worries. But we 
don’t use words like mild cognitive 
impairment. [No] No. We don’t use 
those words. 
Interviewer: What words do you use? 
Margaret: (.) Just we, I can’t remember 
so and so’s name when I meet them, 
and you know (.) I I went to the shops 
and I couldn’t remember what I’d come 
for and I go upstairs and I get to the top 
of the stairs and I can’t remember what 
on earth it was I came upstairs for, 
things like that.  
 
The words do not make sense. 
 
 
 
Pause – unsure what to say? 
Moves from “we” (group) to “I” (self) 
– uses herself as example because it is 
not spoken about? 
 
 
Emphasis – surprise?  
Margaret … I don’t think I’ve got too much to 
worry about at the moment, its it is very 
mild whatever it is… 
 
 
Does not use term MCI, does not know 
what “it” is. 
Simon (.) Well, I’m not really sure, but I think 
it’s to do with urm (.) memory (.) not 
remembering things. [Yeah] And (.) but 
you do remember things but (.) not 
entirely, if a if you understand what I 
mean. [Right okay] Urm (.) some 
thing’s I forget altogether. [Right] Urm. 
I don’t know how they can come up 
Frequent pauses – hesitant, no words, 
unsure. 
Do not remember vs do remember – 
confusing discourse. 
Seeking reassurance. 
 
 
“they” – who? 
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with mild when its, what’s the 
difference? [Yeah]  You know mild 
dose of it or (.) fully blown I don’t 
know. 
Emphasis – the word does not fit with 
the experience. 
“mild dose” – like the flue, using illness 
terminology, more familiar. 
Simon Interviewer: How did you feel when 
she told you that you had mild 
cognitive impairment? 
Simon: (.) I thought I hadn’t. [Okay] I 
thought I’m alright like, nothing wrong 
like. [Yeah] Urm, I still sometimes 
think that. [Yeah] But when, when I (.) 
look back on things I do (.) I don’t do 
silly things, but, I don’t finish anything 
off. [Right ok] Urm (.) I lose interest in 
things which I’ve never done that 
before. I’ve always started a job and 
finished it. [Yeah] (.) And it’s just them 
sort of things you know, it’s (.) it’s just 
strange in a way. [Yeah] I can’t seem to 
concentrate.  
 
 
 
“I thought” – repetition. 
“I’m alright like, nothing wrong like” – 
rephrasing answer, same meaning – 
emphasis? 
Observing/monitoring himself. 
“I don’t do silly things” – caveat, 
justification. 
 
 
 
“just strange” – no other way to 
describe. 
William Interviewer: … can say what you think 
mild cognitive impairment is. 
William: Well, urm (.) it’s loss of 
memory (.) and I suppose loss of 
concentration levels. [Right] Tha tha 
that’s how I understand it.  
 
 
Pauses, disjointed – needs time. 
Repetition “loss” – emphasis. 
Repetition “tha” – unsure what to say. 
William Interviewer: … Yeah, do you, your 
friends still go to the pub quizzes? 
William: Yes. [Right] Yeah they’re all 
asking me to go but no. I’m not, I’m not 
going. [No] (.) Ask me a simple a 
question and you don’t know, you look, 
feel like a fool don’t you. [Right, okay] 
Well I do anyway so.  
 
 
 
Quiet, repetition – emphasis.  
“me” vs “you” – changes subject. 
 
Emotive language, unwanted 
description of himself – how others 
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may view him? 
 
Knowing – Ageing and Dying 
Name Extract of Transcription Findings 
Gwen Well I think of (NAME) getting old but 
I don’t think of myself as getting older. 
[Yeah] You know you think oh I’m just 
me.  
Comparing, putting herself in a 
different position. 
Gwen It’s one of those things you can’t help, 
you’re getting older, you’re getting old. 
Blame should not be attributed to her. 
“older” vs “old” – becomes more 
definite. 
Gwen … You know so I, I don’t want to leave 
any hassle, if I go… 
Repetition – how to say it. 
“hassle” – burden.  
“if I go” – death implied, not explicitly 
stated. 
Clive Like they say, the older you get the 
more cells in the brain that die. [Yeah] 
Well (.) is it cells dying that do the 
memory thing? Are they dying? 
“they” – who? Who is the expert? 
Cells dying as cause of memory loss – 
due to ageing. 
Interviewer put in expert position. 
Clive You know it’s those sort of problems, 
they aggravate you to death. 
 
Emotions cause death? Emphasising the 
effect of the problems reported. 
Jack I think they (family) worry to the extent 
that you do with any (laughs) elderly 
relative. You know, I mean, my son (.) 
still talks to me like I’m an idiot 
(laughs), you know! And has done 
since he was a teenager! And my 
daughters 37 and she she’s the youngest 
and she um, she just talks over me 
sometimes and I just think, will you 
shut up (laughs)! You know. But that’s 
typical of your own kids, but I don’t 
think they actively think of me of of 
 
“elderly relative” – older people create 
worry. 
“still” – always has done. Views of 
older generations. 
 
 
No space for him – younger generation 
takes over. 
Tentatively fighting against ageing 
discourse. 
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urm going into lunacy or anything like 
that. You know. 
“lunacy” – emotive word. 
What else? Dementia? 
Jack (.) Well I think it’s just, (.) the synapse 
in your brain sort of break down after a 
while, it’s (.) they say it’s in your teens 
that your brains the best, and after that 
it sort of starts to wear away a bit. And 
I think, I just think it’s that, you know, 
you get sort of, nibbles out of the edges 
(laughs). [Right!] Urm and it it just, 
you find that you’re just not quite up to 
the mark you were before, thinking 
wise and remembering. Ur and apart 
from that it doesn’t affect you 
physically, well not to my mind. [No, 
no] What mind I’ve got left (laughs)! 
Pause – time to think. 
“synapse” – technical language. 
“they” – who? Viewed as an expert. 
 
 
 
Imagery – making sense using his own 
language. 
 
“mark” – like at school? 
 
“you” – externalising. 
Quiet – difficult to say, turns to 
humour. 
Margaret It was a little bit, shocking I suppose in 
a way (.) but just a month ago I was 
told that I had cancer, so. [Oh gosh] 
You just think to yourself, which is 
worse you know. It’s all part of old age. 
It’s the old vehicle, you know (.) 
having problems in its different parts I 
suppose. [Yeah] So (.) compared with 
that diagnosis, the mild cognitive 
impairment one, ur wasn’t quite in that 
league. 
Conflict – minimising the amount of 
shock? She already knew? 
 “but” – something else more shocking, 
in contrast. 
“all part” – making sense through 
normal ageing, expected. 
Machine metaphor – more familiar 
discourse to make sense. 
“that” – cancer emphasised but 
nameless. 
League of illnesses. 
Margaret Ahh when I first retired (.) I I went 
from somebody who, you know, I felt, 
was important in life, well not 
important that’s the wrong word (.) 
capable and (.) and then all of a sudden 
you wake up one morning and you’re 
just plain old Mrs so and so, OAP. 
 
 
Viewed socially as important, useful. 
 
 
“I” vs “you” – distancing from ageing. 
Nameless, categorised. 
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[Yeah] That’s I think why we started 
this group because it was a chance to 
give back a bit of that. Because in work 
I I used to be involved with groups. 
[Yeah] So it was a nice way of giving 
that back. And there are so many, very 
lonely old people out there (.) but it’s 
sometimes difficult to get them to join a 
group, you know. [Yeah] They tend to 
be (.) you have to really find them, or 
someone else finds them for you.  
 
 
“that” – what does she want to give 
back? 
 
 
How old people are viewed by others. 
 
 
Old age is hidden away. 
 
Margaret … And you feel you want to really 
cherish every moment really. That’s the 
feeling. [Yeah] (.) And the thought of 
having to leave family one day, that’s 
fairly horrific as well. 
you” detaches, something she ought to 
say? 
 
Death/dying implied, not said. 
Emotive language. 
Simon (.) I just look at it as if it’s (.) there’s 
other people worse off (.) you know. (.) 
Try not to complain really. [Yeah] Cos 
obviously get things the older you get. 
Pauses – reflection, time to think.  
Hierarchy of illness. 
 
Inevitable, expected with ageing. 
William Interviewer: … And how, what was 
their reaction? (referring to his friends) 
William: Oh the usual thing, it’s your 
age, things like that you know (.) 
nothing (.) derogatory or nothing, they 
all understood. [Yeah] They’re a very 
good bunch. [Yeah] So yeah, (.) yeah 
I’ve had a lot of support from them. 
 
 
“usual thing” “it’s your age” – well 
known discourse – ageing. 
Pauses – unsure, difficult to talk about. 
“They’re” vs “I’ve” – no longer 
positioned within the group, detached. 
William I was 62, so I’m not old. [No] I still act 
like a fool (laughs) when I go out I still 
have a good laugh. [Yeah] Well I, when 
you say old people you think of people 
with Zimmer frames and things like 
that, you know. [Yeah] I suppose I am 
Fighting against societal views of old 
age. “fool” – associated with younger 
generation, stated in context of being 
viewed as young. 
Societal views of old age. 
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an old person to some people. (.) 
[Yeah] If you’re 15, I’m an old person, 
you know. (.) It’s all relative really. 
Perceptions based on context. 
 
Not Wanting to Know – Dementia 
Name Extract of Transcription Findings 
Clive Well I have a dread about having to go 
into an old people’s home, suffering 
from dementia. [Right] Or that sort of 
thing you know.  
“dread” – fear. “having to go” – no 
choice. “suffering” – illness/disability 
reference? 
Clive I know a lot of people suffer with 
dementia, and it’s an awful affliction. 
(..) Alright they’re starting to get (.) to 
be able to work out what’s causing it 
and what the (.) best way to treat it is. 
They’ve got drugs now I think haven’t 
they? Or they’re experimenting with 
drugs to try and ur reduce it. They said 
they will never cure it. But they’ll slow 
it down so it’s (.) you’re not living like 
a cabbage like for like 10 years, or 
them last years of your life. 
“suffer” repetitive word – associated 
with dementia? “awful” – emotive. 
Repetitive “they” – who? Who is the 
expert? 
Pauses, fluent content – difficult to talk 
about, say the words. 
 
 
 
 
Emotive language.  
Andrew Just cos you’ve got slight memory loss, 
doesn’t say you’re an idiot or not 
responsible for what you’re saying like.  
“just” “slight” – justifying, minimising. 
Not viewed as being able to contribute 
to society/discourse. Memory loss 
viewed as under umbrella of dementia? 
Andrew This all, this all comes back to the 
mechanical self you know, this a 
mechanical reaction, you know. Oh 
aye. I I don’t know, I don’t know if I 
think they’ll ever cure it, but if I can 
reduce it. 
Repetition – what to say. 
Machine metaphor/reference. 
 
Repetition – uncertain. 
“they” vs “I” – they cannot make it 
better but he can reduce it – he is the 
expert. 
Jack Interviewer: How how do you compare  
Appendix 2.8  
253 
 
yourself, the problems you have with 
the problems that your father had with? 
(previously stated father had dementia) 
Jack: Oh well that was much more 
severe because I mean he’d lost all idea 
of who he was, who anybody else was, 
where he was, you know, he was just, 
he’d gone into senility really, you know. 
Urr (.) of course you say to yourself I 
don’t want to be like that (.) and I still 
don’t (laughs)!  
 
 
 
“Oh well that” – distancing.  
“much more” – emphasis, distancing. 
 
 
Old age vs dementia. 
Distancing self from dementia 
 
Humour masks difficult, emotive topic. 
Jack Interviewer: So a lot more than just 
short term memory loss. (talking about 
father’s problems) 
Jack: Oh complete loss. Yeah.  
 
 
 
“complete” – physical, mental and 
identity. 
Margaret … It doesn’t feel as severe, as 
Alzheimer’s yes it would be. We’ve got 
a friend, younger than us, and his wife 
got it and he’s lost her completely. She 
doesn’t know who he is and they were 
such a happy married, couple. [Yeah] 
And, terrible grief that has affected 
him. He’s lost her, he feels completely 
 
Alzheimer’s is viewed as severe. 
Less expected in younger people? 
She has gone, her identity has gone. 
No longer happily married. 
 
 
Repetition. 
Margaret Margaret: … So it seems to take people 
in different ways. I think mines the very 
gradual way, perhaps, I don’t know. 
Interviewer: Do you mean the way to d 
dementia? 
 
Margaret: Yes. Yes. I think so. You can 
stave it off if you, you know if you 
keep active and all the rest of it. The 
newspapers are full of how to avoid it 
“it” – nameless, lose people? 
Own perception of prognosis reduces in 
certainty. 
Hesitation – unsure whether to name 
“it”? Dementia unspoken/ not spoken 
about/hidden away? 
“You” – externalising. “stave” – fight 
against. 
Vague, lots of ways to “stave” it off? 
Who is the expert? Margaret, 
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anyway, aren’t they? We get lots of 
urm (.) advice how to avoid dementia.  
newspaper or interviewer? 
“advice” – not definitive, opinions. 
Simon … I suppose there’s different levels of 
it (.) like, it’s mild what I’ve got. (.) I 
mean what’s someone look like or 
sound like that’s got, a severe case of it. 
Are they urrr, (.) would they be 
hospitalised or? I don’t know. [Yeah. 
Yeah (.) Urm] Or in a home or 
whatever. [Yeah] I mean I don’t want 
that to happen to me. If, will mine go (.) 
worse or what? 
“different levels” – like a hierarchy of 
memory loss. 
 
“severe case” – not explicitly 
mentioned dementia – is this what he is 
referring to or not? 
“in a home” – dementia? Ageing? 
 
 
Putting interviewer in expert position. 
William … Cos I don’t I don’t want dementia (.) 
you know, I’m still young. (laughs) (.) 
No. We’ll see how it goes anyway. 
“I don’t” – repetition, difficult to say. 
Quiet – emotive? 
Laughs – minimising, masking emotive 
aspect of what he previously said. 
William Well it’s in the package they give me 
it’s early onset, Alzheimer’s and all 
this, and I thought well that’s not going 
to happen to me. (.) So I’m not, I’m not 
going to sit here worrying about it, I 
know a lot of people would. [Yeah] 
Well let it get on with it, if it happens it 
happens. [Yeah] I won’t know will I 
(laughs)! 
“package” – lots of information? 
“and all this” – too much information? 
 
Repetition “I’m not” followed by 
louder speech – fighting against 
dementia discourse. 
Inevitable – means no need to worry. 
 
Laughs – masking, minimising. 
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